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ABSTRACT 
A new method of purification has been developed for 
peptides synthesised by the Nerrifield solid phase 
methodology. 
Na_17_Tetrabenzo(a, c,g, i) fluorenylmethoxycarbony]. glycine 
(Tbfmoc Gly OH) has been prepared, and coupled via its 
symmetrical anhydride or its HOBt ester to the N-terminus 
of a peptide at the final stage of the synthesis. 
The strong affinity of the Tbfmoc group for graphitised 
carbon (PGC) allows the retention of Tbfmoc-protected 
peptides on a column packed with this material, whilst 
incorrectly terminated sequences and other materials are 
washed away. Following deprotection of the Tbfmoc group 
under basic conditions, the free peptide can be eluted 
from the column. 
This method has been exemplified by the purification of 
Ubiquitin (53-76) OH and Ubiquitin (35-76) OH. 
Preliminary results indicate that the technique may be 
developed into a form of affinity purification suitable 
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Bnpeoc 2, 2-bis- (4-nitrophenyl) ethoxycarbonyl 
Boc tert-butyloxycarbonyl 
BOP benzotriazole-1-yl-oxy-tris- (dimethyl- 
amino) phosphonium hexafluorophosphate 
Bpoc 2- (4-biphenyl) propyl-2-oxycarbonyl 
DCC 1, 3-dicyclohexylcarbodiixnide 
DCCC droplet counter-current chromatography 
DCM dichloromethane 
DIBAL-H diisobutylaluminium hydride 
DIC 1,3-diisopropylcarbodiimide 
DMF N,N-dimethylformamide 
DMS dimethyl suiphide 
DMSO dimethyl suiphoxide 
DVB divinylbenzene 
EDTA ethylenediaminetetraacetjc acid 
EEDQ N-ethoxycarbonyl-2-ethoxy-1, 2-dihydro- 
quinol me 
El electron impact ionisation 
FAB fast atom bombardment 
Fmoc 9-fluorenylinethoxycarbonyl 
HIC hydrophobic-interaction chromatography 
HOBt l-hydroxybenzotriazole 
HONSu N-hydroxysuccinimide 
HPLC high performance liquid chromatography 
IR infrared. 
Mbh 4,4 1 -dimethoxybenzhydryl 
n.m.r. nuclear magnetic resonance 
P polystyrene 
PAN phenylacetamidomethyl 
Pcc pyridinium chlorochromate 
PDC pyridinium dichroinate 
PGC porous graphitised carbon 
Pmc 2,2,5,7, 8-pentamethylchroman-6- 
sulphonyl 
Pon 4- [4- (oxymethyl) phenylacetoxy- 
methyl) -3-nitrobenzamidoniethyl 
Pop 2- [4- (oxymethyl) phenylacetoxy] - 
propionyl 
PPA polyphosphoric acid 
Ppoc 2-phenylpropyl-2 -oxycarbonyl 
R resin support 
SPPS solid phase peptide synthesis 
Tbfm 17-tetrabenzo(a,c,g, i)fluorenyl- 
methyl 
Tbfmoc 17-tetrabenzo(a,c,g, i) fluorenyl- 
methoxycarbonyl 
TBTU 2-(lH-benzotriazol-1-yl)-1, 1,3,3- 
tetramethyluronium tetrafluoroborate 
THF tetrahydrofuran 
t.l.c. thin layer chromatography 
TFA trifluoroacetic acid 
Z benzyloxycarbonyl 
1 
CHAPTER 1 : INTRODUCTION 
1.1 SOLID PHASE PEPTIDE SYNTHESIS 
1.1.1 Introduction 
Peptide chemistry was founded at the turn of the 
century by Emil Fischer 1 and Theodor Curtius and since 
then has been developed into an area of great 
sophistication. The basic requirement of peptide 
chemistry is to protect both the carboxyl group of one 
amino acid and the amino group of the other to direct 
synthesis towards the desired peptide product. Subsequent 
activation of the free carboxyl group followed by 
selective removal of the protecting groups after peptide 
bond formation, gave the first dipeptide. 
A major achievement in the history of peptide 
chemistry was the introduction in 1963 of solid phase 
peptide synthesis (SPPS) by Merrifield 2 , for which he was 
awarded the Nobel Prize in 1984. He introduced the 
concept of peptide synthesis on an insoluble polymeric 
2 
support in order to overcome many of the problems of 
peptide synthesis in solution (such as poor solubility of 
large or protected peptides and the need for purification 
and characterisation of intermediates). 
1.1.2 The Solid Phase PrinciDle 
The principle of SPPS is simple. The growing peptide 
chain is elaborated while covalently attached to an 
insoluble polymeric support. 
This technique has several advantages over the 
solution phase method: 
Physical losses are minimised by the use of a single 
reaction vessel at all times. 
The assembly of peptide chain is greatly accelerated 
and simplified as intermediate purification is 
eliminated. 
Reactions can be driven to completion using excess 
reagents. 	This allows a high efficiency in the 
various chemical steps and thereby increases the 
overall yield of product. 	Excess reagents and by- 
products can easily be removed by filtration. 
The repetitive steps can be automated. 	This is an 
enormous time and labour advantage over solution phase 
chemistry. 
The standard protocol for SPPS developed by 
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The polymeric support chosen was polystyrene cross-
linked with 1% divinylbenzene (DVB). Functionalisation 
of the resin was achieved by chioromethylation 
(C1CH 20CH 3/ZnCl 2 ). The caesiuin salt of the first 
na_tert_butyloxycarbonyl (Boc) protected amino acid was 
reacted with the chioromethylated resin. After removal of 
the Boc group using trifluoroacetic acid (TFA), the 
resulting salt was basified with a tertiary amine to 
regenerate the cr-amino function. The next Na_Boc 
protected amino acid was then activated with dicyclohexyl-
carbodiimide (DCC) and coupled to the first residue. The 
steps of deprotection, basification and coupling were then 
repeated to extend the peptide chain. Finally, the 
completed peptide was detached from the support using 
anhydrous HF at 0°C and subsequently purified. 
1.1.3 The Polymer Suort 
The major requirements for a suitable support are 
outlined below: 
The support must be capable of a high degree of 
functionalisation to give a useful yield of peptide. 
It must be stable to the physical and chemical 
conditions of the synthesis. 
It must allow rapid contact between the growing 
peptide chain and the reagents. 
It must be readily separable at every stage.. 
4 
Nerrifield found the most satisfactory material to be 
a gel prepared by copolymerisation of styrene with 1% 
divinyibenzene2 . It provided a totally insoluble resin, 
mechanically robust and possessing good swelling 
properties in organic solvents such as dichioromethane 
(DCM) or N,N -dimethylformamide (DMF). 
Other solid supports such as polysaccharides, silica, 
porous glass and polyacrylaniides have also been examined 
and employed in solid phase synthesis from time to time. 
Of these, perhaps the most significant have been the 
polyamide resins developed by Sheppard 4 ; 68 . They were 
specifically designed to overcome the problems of 
synthesising, in good yield, some particularly troublesome 
sequences of peptides (e.g. residues 65-74 of acyl carrier 
protein) 4 1 5. 
More recently, Sheppard has introduced the more robust 
polyamide resin supported on kieselguhr9 , suitable for 
continuous-flow SPPS. 
1.1.4 The Petide-Resin Link 
In the original method, the use of 50% TFA in DCM for 
the repetitive removal of the Boc group, was found to 
cleave the benzyl ester linkage between the peptide and 
the resin by about 1% per cycle 10 , which is barely 
acceptable. A solution to this problem was the 
introduction by Merrifield of the phenylacetamidomethyl 




The electron withdrawing effect of the acetainido group 
was found to increase the stability of the peptide esters 
of (1) towards acids by a factor of 100. However, 
cleavage of the PAM resin and simultaneous side chain 
deprotection in the final step required the use of 
anhydrous HF which can cause damage to the peptide itself 
and has been found to be incompatible with some 
scavengers 12 . To reduce these side reactions to a 
minimum, notable success has been obtained with the 
introduction of the HF/DMS (low-high) methodology 13 . 
A far more flexible approach to the solid phase 
synthesis of large peptides has been the development of 
the p-alkoxybenzyl alcohol resin 14 ' 15 (2).. 
HOCH20O-CH2©.® 
(2) 
In this case, the electron donation by the para alkoxy 
group stabilises the incipient benzylic carbonium ion and 
hence enables cleavage of the peptide from the resin under 
6 
milder conditions (50% TFA in DCM). The p-alkoxybenzyl-
alcohol resin has been extensively used in an orthogonal 
strategy with the base-labile 9-fluorenylmethoxycarbony]. 
(Fmoc) amino protecting group 1618 . 
Other handles have also been reported which allow a 
three-dimensional orthogonal strategy. The advantage of 
such an approach is the opportunity to synthesise 
protected fragments. This in turn allows a fragment 
condensation approach for the synthesis of peptides to be 
adopted. For example a fluoride-labile linker has been 
reported by Barany 19 , and more recently, the 2-(4-hydroxy-
methylphenyl) -2-trimethylsilyl-propanoic acid handle (3) 
has been successfully used by Ramage 20 as an alternative 
fluoride-labile linker. 
HO- CH2 CH-CH2-c00H 
Si(CH3 )3 
(3) 
Rich21 and Tjoeng22 have introduced photolabile 
handles while Nerrifield 23 i 24 has developed the multi-
detachable Pop and Pon-resins (4), (5), in which two ester 
bonds can selectively be cleaved by different reagents, to 
give a peptide in various stages of deprotection. 
VA 
o4 	o4 o 
It 	 II 
Boc- NH - CH --O - CH 2 -CH2-C-O-CH-C...J 
k 	 CH 3 
tert -butoxycarbonylaminoacyl-2-[4-(oxymethyl)phenylacetoxy]-
propionyl Pop-resin (4) 
0 
II 
- BOC-NH-CH-C-O 	 NH-CH2 0 P 
R 1 
NO2 
tert-butoxycarbonylaminoacyl-4- [4- (oxymethyl) phenylacetoxy-
methyl]-3-nitrobenzainidoinethyl Pon-resin (5). 
Finally, other acid-labile handles have been developed 
to produce peptide ainides, including those derived from 
the benzhydrylamine-resin2526 (6) and the more recent 
xanthenyl-resin (7) reported by Sieber 27 . 
NH2-CH 0 P _~Do 
0 
(6) 
EIIII0I1O - C H 2  0 
(7) 
8 
- 	In both cases cleavage of the -peptide amides can be 
performed using very mild acidolysis. 
1.1.5 	 Grours 
Though many protecting groups have been recommended, 
only a few have found general application. 
- Among these, the urethane-type amino protecting group 
(8) has been widely used for the important reason that 




The first urethane group, the benzylóxycarbonyl (Z) 
group (9) was introduced by Bergmann and Zervas in 1932 28 . 
' -CH2- O-- 
 
Removal of this group may be achieved by a number of 
methods including catalytic hydrogenolysis, acid-catalysed 
solvolysis in HBr/CH 3 COOH and reduction using sodium in 
liquid ammonia. 
9 
An alternative to the Z group has been the Boc 29 group 
which can be cleaved using 50% TFA in DCN. 
Extensive work has been done on acid sensitive 
Na_protecting groups such as Ppoc 30 (10) or Bpoc 31 (11) 
and has shown that their cleavage can be performed under 
very mildly acidic conditions. 
CH3  0 CH 3 0  11 
0 	1 ~DOCH3 
2 -phenyipropyl -2 -oxycarbonyl 	2- (4-biphenyl) propyl-2- 
oxycarbonyl 
Ppoc (10) 	 Bpoc (11) 
However, a major problem in using acid-labile urethane 
protecting groups is the generation of relatively 
long-lived carboniuin ions on acidolytic cleavage. These 
highly reactive species can modify the side chain 
functionality of tryptophan 3 li 32 , tyrosine 33 , inethionine 
and cysteine 34 , necessitating the presence of scavengers 
such as anisole, thioanisole and 1,2-ethanedithio]. during 
the deprotection step. 
In comparison to acid-labile protecting groups, the 
base-labile protecting group Fmoc35 , 36 offers considerable 
advantages: 
1. The mild conditions of removal (via -e1imination) 
reduce the number of side reactions inherent in 
10 
repetitive acidolysis. 
2. The possibility of using this group along with 
acid-labile side-chain protection allows an orthogonal 
strategy to be adopted. 
The Finoc, t-butyl, alkoxybenzyl ester methodology has 
become a successful strategy for peptide synthesis 
combining mild conditions with efficiency. 
Recently, the 2, 2-bis-(4 -nitrophenyl)ethoxycarbonyj. 
(Bnpeoc) group37 ' 38 (12) has been developed as an 
alternative base-labile Na_protecting group and offers 





1.1.6 Side-Chain Protection 
In SPPS, reaction conditions tend to be rather severe: 
large excess of reagents and extended reaction times are 
used. For these reasons, the protection of side-chain 
functional groups is necessary. 
We have successfully used the Finoc, t-butyl, alkoxy-
benzyl ester methodology in which the following acid-
labile side-chain protecting groups were employed: 
11 
r-trityl for histidine, Pmc 39 ' 40 for arginine, Mbh41 for 
asparagine and glutainine, and tert-butyl for tyrosine, 
glutamic and aspartic acid, threonine, and serine. 
A large number of protecting groups for amino acid 
side-chain functions have been reported in the literature. 
Although these are not described here, some excellent 
reviews4244 exist on this topic. 
1.1.7 Coupling Methods 
The formation of a peptide bond requires nucleophilic 
attack of the or-amino group of one amino acid upon the 
activated carboxyl function of another. 
Obtaining optimal conditions for the coupling 
reactions is of crucial importance in SPPS as mixtures of 
free-peptide products are often difficult to separate. 
For this reason much effort has been put into the search 
for activating procedures which effect rapid and clean 
acylations of ainines without side reactions. 
One of the major potential side reactions is 
racemisation which can proceed through a mechanism 
involving a 5(4H)-oxazolone formation45 . Numerous studies 
on the racemisation dependence of different peptide 
coupling methods have revealed that only a few techniques 
are suitable for routine synthesis. 
Some of the most prominent methods and reagents are 
discussed below. 
12 
The Acid Chloride Method 
Na-protected amino acid chlorides are very reactive 
and were tried out in solution phase peptide synthesis 
around the turn of the century46 ; their use in SPPS has 
remained very limited. 
Conversion of the carboxyl group of a protected amino 
acid to the acid chloride generally requires the use of 
thionyl chloride or oxalyl chloride in DCM. Under the 
reaction conditions, some Na_protecting groups (i.e. Boc) 
are not completely stable and give rise to the formation 
of N-carboxyanhydrides 47 . Other problems, which limit 
their use in peptide chemistry are racemisation and the 
high level of unwanted side reactions. 
Despite these considerable drawbacks, the revival of 
the acid chloride method has been made possible through 
the introduction of novel acid-stable Na_protecting 
groups. The Fmoc group was found to be stable during acid 
chloride preparation with thionyl chloride 48 . Further-
more, Fmoc amino acid chlorides having aliphatic 
side-chains are stable compounds48 and have been shown to 
react rapidly in solution and in solid phase synthesis 
with very low levels of racemisation4849 . 
The Azide Method 
The azide method 50. has been shown to be one of the 
safest methods to avoid raceinisation. 
Azides can be generated from alkyl esters via the 
formation of hydrazides (Scheme 2). 
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0 	 0 	 0 	 0 II N H 	II HNO 	II II R-C-OCH 3 	R-C-NH-NH2 	2 R-C-N 3 > R-C-NH-Y+HN 3 
Scheme 2. Peptide synthesis by azide coupling 
Following recent improvements of the method, direct 
conversion of carboxylic acids to acid azides is now 
possible with the use of diphenyiphosphoryl azide 51 . 
Alkyl nitrites, in place of nitrous acid, may also be used 
for the transformation of hydrazides to azides 52 . 
The possible drawbacks of the method are the 
generation of the highly toxic hydrazoic acid during 
acylation and the Curtius rearrangement leading to the 
formation of urea derivatives 53 . 
The Anhydride Method 
Mixed anhydrides between Na_protected amino acids and 
a variety of other acids were introduced in peptide 
chemistry in the early forties. 
Among these, the mixed carboxylic-carbonic anhydrides 
have been the most popular. Due to their instability over 
long periods, they are usually prepared at low temperature 
immediately prior to coupling using reagents such as 
ethyl 54 s 55 or isobutyl chloroformate 56 (Scheme 3). 
14 
0 	 0 0 
II base 	II 	II R-COOH + Cl-C-O--alkyl 	) R-C-O-C-O-alkyl 
0 
NH 2 _Y 	II ) R-C--NH-Y + CO 2 + alkyl OH 
Scheme 3. 	Mixed anhydride method with alkyl chioro- 
formate as activating agent. 
The use of phosphinic-carboxylic mixed anhydrides has 
also been investigated. In particular diphenyiphosphinyl 
chloride57 , 1-oxo-1-chlorophospholane 58 and recently 
diphenylphosphinic anhydride59 have been successfully used 
as reagents in both solution 57 and solid phase 
synthesis59 ' 60 • 
With symmetrical anhydrides, there is no ambiguity 
concerning which carbonyl is attacked by the amine, and 
they react exceptionally cleanly and in high yield. Their 
disadvantage is that two equivalents of expensive amino 
acid derivative are required to generate one of the active 
species. 
Symmetrical anhydrides are stable and have been stored 
cold for long periods, but are commonly prepared 
immediately prior to use with a reagent such as DCC. 
The Active Ester Method 
Schwyzer was the first to recognise that an increase 
in the reactivity of alkyl esters 6163 was necessary for 
the formation of the peptide bond and introduced cyano- 
15 
methyl esters 64 . 
In this case, the electron-withdrawing effect of the 
cyano group renders the carbon atom of the carbonyl group 
more electrophilic. They have not been generally adopted 
in peptide synthesis, as satisfactory rates are only 
obtained when the reactants are used in large excess. 
Aryl esters proved to be more powerful, and 
enhancement of their inherent reactivity by electro-
negative substituents gave rise to a whole series of 
acylating agents. Noteworthy examples are p-nitro-
phenyl 65 , 2,4,5-trichlorophenyl 66 and pentachloro or 
pentafluorophenyl esters67 , although the last two have a 
possible problem with steric hindrance. 
More recently, active esters of 1-hydroxybenzo-
triazole68 (HOBt) and N-hydroxysuccinimide 69 (HONSu) have 
gained considerable popularity among peptide chemists. 
These esters may be preformed or generated in situ, are 
highly reactive and have substantially improved coupling 
reactions in some difficult sequences. 
Coupling Reagents 
The main advantage of coupling reagents such as DCC 70 
is that they can be added to Na_protected amino acids in 
the presence of the amino component. Thus, in situ 
activation can be achieved immediately prior to or at the 
time of the coupling. 
DCC is highly reactive and its ease of application has 
16 
made it the most frequently used reagent in peptide 
synthesis (Scheme 4). 
R-COOH + ON=C=N-o 
(DCC) 
1 
II 0 #NHQ 0 0 II R-C-O C R--N-C-NH-1 
(13) . 0 	0  (14) 
H0-X/' 	JNHY \\R-COOH  
0 	 0 	 00 II II I, 	it 
R-C-O-X 	' R-C-NH-Y 	R-C-O-C-R 
active ester 	peptide 	symmetrical anhydride 
Scheme 4. Peptide Formation with DCC. 
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However, there are several disadvantages which limit 
the use of DCC. Compound (13) can spontaneously rearrange 
to the unreactive by-product N-acylurea (14). Further-
more, the high reactivity of intermediate (13) can lead to 
oxazolone formation during fragment condensation. Both 
these problems can be avoided by the addition of auxiliary 
nucleophiles such as HOBt 71 to give in situ active ester 
formation. 
Different carbodiimides are available; DCC gives as 
by-product dicyclohexylurea which in some solvents can be 
separated almost quantitatively from soluble peptide 
derivatives by simple filtration. On the other hand, di-
isopropylcarbodiimide (DIC) has found favour in SPPS. It 
gives the much more soluble diisopropylurea which can be 
easily washed out together with excess amino acid 
derivatives and reagents. 
The success of DCC has prompted a further search 
for even better coupling reagents. 	Some examples are 
carbonyldiimidazole72 , 	N-ethoxycarbonyl-2-ethoxy-1, 2- 
dihydroquinoline (EEDQ) 73 and some phosphonium derivatives 
such as the benzotriazole-1-yl-oxy-tris- (dimethylamino) - 
phosphonium hexafluorophosphate (BOP) reagent 74 and 2-(lH-
benzotriazol-l-yl) -1,1,3, 3-tetramethyluronium tetrafluoro- 
borate (TBTU) 75 recently developed by Knorr. 
This is by no means an exhaustive list of the coupling 
methods available to the peptide chemist. There are 
excellent reviews on this subject7677 ; in particular 
18 
Hudson has recently compared different coupling procedures 
and has selected BOP in the presence of HOBt as the best 
coupling reagent78 . 
1.1.8 Monitoring and CaDing 
Despite the use of highly efficient coupling 
techniques, acylation reactions cannot be assumed to go to 
completion. Some sequence effects such as steric 
hindrance or the folding of the growing peptide chain can 
result in some dramatic drops in the coupling efficiencies 
as synthesis progresses. However, for long peptide 
syntheses coupling and deprotection steps must be driven 
virtually to completion (-99.9%), as even a slight 
lowering in efficiency will produce deletion peptides and 
complicate purification. 
Monitoring of both acylation and deprotectiori 
reactions can therefore help to identify these failures. 
Several monitoring techniques, such as ninhydrin 
(Kaiser test) 79 ' 80 , picric acid 81 , 2,4,6-trinitrobenzene-
suiphonic acid 82 , fluorescamine83 11 and chlorani1 84 11 are 
based upon the reaction of a reagent with free amino 
groups to form a coloured compound. Other techniques 
include: titration with perchloric acid 85 1 specific 
absorption in the ultraviolet of the eliminated material 
produced during acylation (e.g. 3,4-dihydro-4-oxo-1,2,3-
benzotriazine) 86, and continuous spectrophotometric 
monitoring of the reaction when Finoc-derivatives are 
19 
used87 . 
The most popular method remains, however, the 
qualitative colour test with ninhydrin 79 . 
A method to circumvent the formation of deletion 
peptides is to covalently block (cap) with a powerful 
acylating reagent the residual free a-amino groups where 
peptide coupling has failed. Eventual separation of the 
terminated peptides from the desired product is in theory 
simpler due to the differences in charge or solubility 
conferred by the blocking group. 
The capping procedure is usually performed with acetic 
anhydride in the presence of a secondary or tertiary base 
in DC)! or DMF2 . Other acylating reagents such as 
N-acetylimidazole88 , isopropenyl formate89 1 fluoresc-
amine90 , 3-nitrophthalic anhydride 93- and 3-sulphopropanoic 
acid anhydride92 , have also been used as an alternative to 
acetic anhydride. 
1.2 PEPTIDE PURIFICATION 
1.2.1 Introduction 
There are a great many separation techniques available 
for the isolation and purification of peptides and 
proteins. Small peptides can often be separated from by-
products by standard techniques such as gel filtration, 
ion exchange and high-performance liquid chromatography, 
which exploit the physico-chexnical properties of 
molecules. Purification of larger synthetic peptides or 
20 
proteins is more difficult to achieve as the differences 
in physical or chemical properties are relatively smaller. 
These difficulties are magnified with the stepwise solid 
phase method, where purification is possible only at the 
end of the synthesis. In this case, highly selective 
purification techniques, such as affinity chromatography, 
can be extremely useful as alternatives to the standard 
purification methods. 
Optiinising the separation of a complex peptide mixture 
should not, however, rely on a single purification method 
but should be achieved by a combination of these 
techniques. 
1.2.2 Gel Filtration 
Since its introduction 93 1 gel filtration has occupied 
a key position in the purification of numerous biological 
molecules because of its simplicity and reliability as a 
separation technique. 
The separation in gel filtration depends on the 
differential ability of the molecules to enter the 
stationary portion of the liquid phase through the pores 
in the gel. Very large molecules do not enter the 
stationary phase and move quickly through the 
chromatographic bed whereas smaller molecules, which can 
enter the gel pores, move more slowly through the column. 
Molecules are, therefore, eluted in order of decreasing 
molecular size. 
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Several bead-formed gels derived from dextran 
(Sephadex, Sephacryl) or agarose. (Sepharose) are 
commercially available. They differ in their structures, 
in the degree of cross-linking and are available with 
different fractionation ranges. 
Gel filtration can readily be used for removing 
scavengers, desalting peptides and for buffer exchanges 
(the peptide can be transferred to the appropriate 
starting buffer for subsequent purification techniques). 
With a careful choice of gels and operating conditions, 
this technique can be employed for the fractionation of 
peptides. 
Ultrafiltration membranes have also been used as an 
alternative for removing low molecular weight 
impurities94 . 
1.2.3 Ion Exchange ChromatociraDhy 
Ion exchange chromatography has proved to be a high 
resolution technique for the separation of biological 
molecules. 	' Ion exchange is capable of separating 
molecules with very close isoelectric points. 	This 
characteristic combined with its simplicity of use and a 
good recovery of material has made ion exchange a very 
popular technique. 
An ion exchanger consists of an insoluble matrix to 
which charged groups have been covalently bound. 
Positively charged matrices have negatively charged 
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counter-ions (anions) available 	for exchange, and 
therefore 	are termed anion 	exchangers (vice 	versa for 
cation exchangers). 
The matrix may be based on inorganic compounds (such 
as hydroxyapatite), synthetic resins (e.g. AG, Bio-Rex, 
Chelex), or polysaccharides (e.g. Sephadex, Sepharose and 
Sephacel). The nature of the charaed arouns dtrmins 
the strength of the ion exchanger whereas their total 
number and accessibility are responsible for the capacity. 
Some of these groups are shown in the following table. 
Anion Exchangers Cation Exchangers 
Aminoethyl (AE) Carboxymethyl (CM) 
-OCH 2 CH 2NH? _ocH 2 cooe 
Diethylaminoethyl (DEAE) Phospho 
-OCH 2 CH 2NH(CH 2 c}i0 _p0 4He 
Quaternary aminoethyl (QAE) Suiphopropyl (SP) 
Is 
-O(CH 2 ) 2N(C 2H 5 ) 2 CH 2 CH(OH)CH 3 -CH 2 CH 2 CH 2 SO 
Table 1. Functional groups used for ion exchangers. 
This technique has been widely employed in SPPS for 
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separating the desired free amino peptide product from 
terminated sequences. Where capping reagents such as 
acetic anhydride, N-acetylixnidazole or isopropenyl formate 
have been used, both anion and cation exchange 
chromatography have proved to be useful for isolating the 
peptide of interest. In the case of 3-nitrophthalic 
anhydride, the resulting 2-carboxy-3-nitrobenzoyl 
derivatives are strong acids and can be readily separated 
on an anion exchanger 91 . 3-Suiphopropanoic acid 
anhydride92 as well as the structurally closely related 
2-sulphobenzoic acid anhydride 95 have also been employed 
to facilitate product purification. 
In a reciprocal strategy described by Krieger et al. 96 
(Section 1.2.7), in which a tag (affinity reagent) is 
attached selectively to the desired peptide, ion exchange 
chromatography has also been useful. Suzuki et al. 97 used 
lysine as a highly polar handle (removable by Edman 
degradation) for simplifying the purification of the B 
chain of human insulin. Other examples include the use of 
m or p-sulphophenylisothiocyanate98 , 99 and the 9-(2-
suipho) fluorenylmethyloxycarbony]. (Sulfmoc) group 100 . In 
the latter case, the strongly acidic Sulfxnoc-peptide is 
easily separated from terminated sequences by anion 
exchange chromatography. Removal of the Sulfinoc group can 
be carried out using mild bases to give the desired free 
amino peptide. 
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1.2.4 High Performance Liquid Chromatography 
Reversed-phase HPLC has been by far the most widely 
used mode of HPLC. 
Octadecyl (C 18 ) and octyl (C 8 ) stationary phases, 
chemically bonded on a microparticulate silica gel 
support, have been commonly used as column packing 
materials. Supports containing C and C 4 functionalities 
have occasionally been used for hydrophobic peptides and 
proteins. In this technique, molecules are separated on 
the basis of differences in their hydrophobicities. 
Gradients with an increasing percentage of the organic 
solvent in an aqueous mobile phase are commonly used for 
elution. The ability to separate peptides with closely 
related structures, has made this technique, an extremely 
powerful tool for both analytical and preparative 
purposes. Parameters such as pH, mobile phase, 
counterion, etc. can be varied for optimum resolution. 
The flexibility as well as the rapidity of this technique 
has made it the obvious choice to gauge the complexity of 
a peptide mixture. 
Displacement chromatography is a recently developed 
mode of HPLC101 which also takes advantage of differences 
in the hydrophobicity of molecules. Hydrophobic 
impurities are isolated on a short precoluinn trap while 
hydrophilic impurities are displaced from the column with 
an aqueous mobile phase (0.05% aqueous TFA), leaving the 
main column filled with homogeneous product. A gradient 
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elution is then applied to remove the peptide product from 
the main column. 
This method has been particularly useful for the 
isolation of a synthetic polypeptide which is a promising 
malaria vaccine102 . 
1.2.5 Dro1et Counter-Current ChromatocTraDhy 
Complementary to conventional chromatographic methods, 
droplet counter-current chromatography (DCCC) 103  has been 
widely applied to the isolation of natural products. 
DCCC is a liquid-liquid separation technique relying 
on the partition of a solute between two immiscible 
solvents. 
The main advantages of this technique are outlined 
below: 
As no solid support is present, irreversible 
adsorption is avoided; thus, all material is 
recoverable. 
Quantities ranging from mg to g can easily be handled 
and the solvent consumption is small. 
DCCC is a simple, economical method and is therefore 
particularly suited for preparative large scale 
purification. 
Some applications of DCCC for the purification of 
peptides have been reviewed by Hostettmann 104 . Recently, 
the transferability of this technique on an industrial 
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setting has been clearly demonstrated in the case of 
somatocrinin105 . 
However, the efficiency of the method depends entirely 
upon droplet formation which is a serious limitation. 
Furthermore, separations remain slow (up to several days) 
and resolution is poorer than, for example, HPLC. 
1.2 • 6 HYdrophobic-Interaction Chromatography 
In hydrophobic-interaction chromatography 	(HIC), 
substances are separated on the basis of their varying 
hydrophobic interactions with an uncharged bed material 
containing hydrophobic groups (e.g. octyl and phenyl 
Sepharose). 
This technique has been widely applied for the 
purification of proteins. 	Its application in peptide 
synthesis remains very limited. 	Examples include the 
purification of cr-factor106 and the separation of a 
particular hydrophobic peptide from a complex mixture 107 . 
Recently, HI media have been examined as an 
alternative to reversed-phase media for the resolution of 
peptide mixtures by HPLC. Significant differences in 
selectivity were noted with peptides large enough to 
possess secondary or tertiary structures 108 ' 109 . 
1.2.7 Affinity Chromatography 
Affinity chromatography is a highly selective method 
which allows the purification of molecules on the basis of 
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their biological functions or individual chemical 
structures. This technique makes it possible to remove 
large amounts of undesired materials from the solutions of 
interest. The method has found wide acceptance in 
biological research since its introduction 110 . 
In principle, the method is based on the interactions 
between a specific ligand (covalently bonded to a support) 
and the desired substance. For example, an enzyme bonded 
as the ligand can be used for the purification of a 
substrate analogue, whereas an immobilised antibody may be 
suitable for the purification of an antigen. 
The method involves three stages (Scheme 7). 
Ligond Immobilisotion 
+ ID 	--W b 





Scheme 7. Principle of affinity chromatography. 
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A specific ligand is covalently bound to a 
chromatographic bed material, such as an agarose gel 
(Sepharose 4B, Sepharose CL), previously activated 
(e.g. by cyanogen bromide). 
The gel with the inunobilised ligand is packed into a 
column of suitable dimensions. 	After sample 
application, substances capable of specific 
interactions with the ligand are adsorbed on the 
column, while the non-adsorbed impurities are washed 
away. 
The adsorbed substances are eluted from the column. 
This is usually achieved by either a stepwise or a 
continuous change in properties of the eluent. Non-
selective elution involves pH or ionic strength 
gradients whereas selective elution uses an eluting 
agent (e.g. NaCl, urea) that competes for binding to 
the adsorbed substance or the ligand. 
Affinity chromatography has been employed from time to 
time in SPPS and the general strategy developed by Krieger 
et al. 96 has been particularly useful for the purification 
of numerous synthetic peptides. The method involves 
functional selection of the N-terminal amino acid of the 
peptide by chemical reaction with an affinity reagent A-B, 
bearing an affinity group A and a binding group B. The 
affinity-labelled peptide can be separated from terminated 
sequences by selective binding to an affinity receptor. 
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The affinity-labelled peptide is then dissociated from the 
receptor, and the affinity reagent is finally removed to 
give the peptide of interest. 
Covalent Chromatography 
One suitable affinity reagent has been the dipeptide 
cysteinyl-methionine, which was employed for the 
purification of ribonuclease (111_124) 96 . The desired 
peptide is distinguished from terminated peptide chains by 
attachment of the affinity reagent (cysteinyl-methionirie) 
before removal from the support. The carboxyl group of 
methionine is attached to the N-terminus of the desired 
peptide whereas the thiol group of cysteine can be bound 
to an organomercurial-agarose column (through a covalent 
mercury-sulphur bond). This allows separation of the 
derivatised peptide from terminated sequences lacking the 
affinity group. Following displacement from the column by 
elution with an organic thiol (e.g. cysteine), the peptide 
of interest can be obtained after removing the Cys-Met 
dipeptide by cyanogen bromide cleavage. This technique 
has also enabled the purification of a synthetic 
hexadecapeptide present in the sequence of allergen N from 
cod111 . 
"Functional" Purification 
Since the interactions that form and stabilise the 
structure of proteins are highly characteristic of each 
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molecule, another approach has involved the capacity of 
biologically active peptides for complex formation. 
This principle has been applied to the purification of 
synthetic ribonuclease S-peptide derivatives 112 . The 
latter were prepared by the solid phase method and 
purified by specific complex formation with RNase 
S-protein, which had been immobilised by attaclunent to 
cyanogen bromide activated agarose (Sepharose 4B). 
Hofmann, Smithers and Finn 113 have used a similar approach 
for the purification of synthetic S-peptide (1-20). 
In this instance, advantage was taken of the 
complementary fit of the synthetic peptide onto natural 
S-protein. 
Avidin-Biotin Purification 
The high affinity of avidin for biotin 114 provides an 
example of an affinity purification procedure for large 
peptides, chemically synthesised by solid phase 
methodology. 
The peptide, terminally deprotected and neutralised on 
the resin, is biotinylated with N-hydroxysuccinimido-
biotin. Following cleavage, the crude material is applied 
to an avidin agarose column which is then washed with a 
phosphate buffer, until all unbound material has been 
eluted. The biotinylated peptide is finally eluted with 
0.114 glycine HC1, pH 2.0. 
This method has allowed the purification of several 
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synthetic peptide fragments including [Asp 205 ]-inter-
leukin-1 3 (117-269), present in less than 1% yield in the 
crude HF cleavage mixture 115 . 
Metal Chelate Affinity Chromatography 
In this technique, the separation is achieved by 
differential binding of substances to metal ions 
immobilised by chelation116 . Zn, Cu, Cd, Hg, Co and Ni 
can be imrnobilised on a Sepharose or Sephadex column 
previously derivatised with a metal chelating ligand (e.g. 
iminodiacetic acid). Some amino acids (e.g. histidine, 
cysteine) form complexes with these metal ions, allowing 
the adsorbed peptide or protein to be washed free of 
contaminants in the sample. Elution is usually carried 
out by either lowering the pH of the mobile phase or 
introducing a displacing ligand in the buffer such as 
ethylenediaminetetraacetjc acid (EDTA). 
The potential of this technique has been illustrated 
by the resolution of angiotensins I and II and their seven 
synthetic analogues by HPLC 117 . 
Antibody Binding Chromatography 
Specific antibodies can be induced against almost all 
small molecules, and can be covalently bound to a solid 
support to serve as highly specific sorbents for the 
desired peptides that contain these small molecules. 
The potential of this method has been investigated 
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with the use of anti-dinitrophenyl antibodies for the 
isolation of peptides containing at their N-terminus a 
dinitrophenyl moiety 118 . 
Graphite Based Chromatography 
In a recent article by Knox et al. 119 , the use of 
porous graphitised carbon (PGC) was examined as a 
potential carbon material for HPLC. This material was 
described as a porous 2-dimensional graphite consisting of 
3-10 pm spherical particles having a specific surface area 
of about 150 in 2/g. PGC was found to give good peak shapes 
for elution of a wide range of molecules. It acted as a 
very strong hydrophobic adsorbent and could be deactivated 
by adsorption of high-molecular-weight additives. 
These interesting results suggested to us that the 
strong affinity of PGC for hydrophobic molecules could 
serve as a basis for a new method of purification in 
peptide chemistry. 
Isolation of the desired peptide from terminated 
sequences would be achieved if at the end of the synthesis 
the free amino terminal residue was blocked with a group X 
having the following properties: 
It must be sufficiently large and flat to be retained 
on a PGC column. 
It must be stable to the conditions of final cleavage 
of the peptide from the support (i.e. 95% TFA). 
It must contain a chromophoric group (>inax > 350n1n) in 
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order to enable monitoring. 
The desired peptide temporarily blocked with the 
affinity reagent X should be retained to a greater degree 
than the terminated sequences when passed through a PGC 
column. 
Fluorene derivatives meet the above criteria and were 
therefore chosen for further investigation. 
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CHAPTER 2 : DISCUSSION 
2.1 SYNTHESIS OF DIBENZOFLUORENES AND DERIVATIVES 
Fused diaryifluorenes were selected as the target 
compounds. 
However, a number of possible structures can be 
envisaged depending on the position of the additional 
benzenoid fused rings (Fig. 1). 
wi.. 
Fig. 1 
A review of the literature was undertaken with a view 
to ascertaining which ring system would be most suitable 
for our purpose. We required a compound which would be 
planar, could be prepared in reasonable quantities, and 
could be obtained relatively easily. 
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2.1.1 Historical Background 
Few practicable syntheses have been described. 
Several steps as well as forcing conditions (e.g. heating 
at 300C for several hours) are generally required, and 
poor yields are usually obtained. A number of the more 
relevant methods are outlined below. 
(i) In the method of Bandyopadhyay et al. a Diels-Alder 
reaction was used to synthesise a. useful intermediate 
which on subsequent aromatisation and cyclisation afforded 






l 4O_ 145°C 
i) , nitrobenzene 
HI, red phosphorus, 
+ 140-145°C, 12h 




The yields for this route were moderate and the 
conditions difficult, making it somewhat impractical for a 





(ii) Rahman and Tombesi 121  used a double succinoylation 
of fluorene followed by double cyclisation, reduction and 
aromatisation for their synthesis of 1,2:6,7 dibenzo-







i) (o , A1C1 3 , nitrobenzene, 93% 
KOH/NeOH, 87% 
Huang-Minlon reduction, 80% 
PC1 5 , benzene 
PtO/280-300°C, 40 mm., 82% 
Scheme 9 
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The major drawbacks of this synthesis are the 
cyclisation reactions which lead to the formation of other 
isomers (no yields are given) and the aromatisation step 
which requires heating to 280-300°C in the presence of 
Pto. 
(iii) The synthesis of a polycyclic aromatic ring system 
was also achieved through the use of a Michael addition 122 . 
Ethyl 2-naphthylacetate was condensed with ethyl cinnamate 
to give ethyl a-(2-naphthyl) --phenylglutarate. Hydrolysis 
of the latter followed by cyclisation gave 4-oxo-2-phenyl-
1,2,3, 4-tetrahydrophenanthrene_1_carboxyljc acid. After 
reduction, dehydrogenation and cyclisation of this 
intermediate, 2 0', l'-naphtho[a] fluorenone (17) was 




0 	0 	 00 Michael addition 	 1111* 
Ethyl 2-nophthyl acetate 
Ph 	i ii 	 Ph 
V 
@Y i  
COOH 	fCOOH 00 	00 
 
(17) 
1) Hydrolysis ii) Anhydrous SnC1 2 iii)Huang-Ninlon reduction 
iv) Pd/C 10%, boiling p-cyinene v) H2SO4 
Scheme 10 
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The main disadvantage of this approach lies in the 
last cyclisation step which proceeds with low yield. 
(iv) 	In a further route, phenyl 2-methoxy-l-phenan- 
threnecarboxylate was utilised as a key intermediate 123 . 
Treatment of this compound with phenylinagnesium bromide 
furnished phenyl 2-phenyl-l-phenanthrenecarboxylate in 80% 
yield. Subsequent cyclisation in the presence of conc. 
H2SO4 gave 11H-indeno(2, 1-a)phenanthren-ll-one (18) in 
good yield (Scheme 11). 
Q  0 0 




(v) 	A photochemical method proved successful for the 
synthesis of 13H-dibenzo[a,c]fluorene (15) from 2,3-
diphenylindene 124 . 
In the last two approaches, however, the major 
limitations are the syntheses of the key intermediates 




After considering the literature we decided to aim 
mainly for dibenzo(a,c)fluorenes functionalised at the 
C(13) position (fig. 2) and four possible routes to the 
synthesis of these derivatives were then investigated. 
x 	X:CH 2 -OH 
Fig.2 
	or =o 
2.1.2 Synthesis of Dibenzo(a,c)fluorenes 
The possible cyclisation of 2,3-diphenyl-l-indenone to 
dibenzo(a,c]fluorene-11-one (19) was studied first (Scheme 
12). 
2, 3-Diphenyl-1-indenone 	 (19) 
Scheme 12 
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The cyclisation was attempted by several methods: 
- 	Aid 3 , NaCl, 200°C (Schoil reaction). 
- 	Aid 3 , CH 2 C1 2 , reflux (Friedel-Crafts reaction). 
- 	hv, 1 2 (photochemistry) 125 . 
- hi', 1 2 1 trifluoromethanesuiphonic acid (photo-
chemistry) l25 
Unfortunately, none of these methods resulted in 
formation of the desired product as judged by t.l.c. or 'H 
n.in.r. of the crude material. Either no reaction occurred 
or a black tar was formed. 
This approach was abandoned. 
Although the initial target compounds were dibenzo-
(a, c) f luorenes, we were not confined to this ring system. 
Blum et al. reported the synthesis of dibenzo[b,h]
fluorene-12-one (20)126. 	If we could prepare this 
material and also derivatives functionalised at position 
13, this method would provide a short synthesis of 
compounds suited to our purposes (Scheme 13). 
0 0 	 0 
o 2900 
-41 Rh CII P Ph313 çSZ 




2-Naphthoic anhydride was heated in the presence of 
RhC1[P(C 6 H 5 ) 3 ] 3 catalyst at 290°C, according to the 
literature method. Unfortunately, the desired product 
could not be isolated. 
One possible explanation of this result is that the 
crude 2-naphthoic anhydride used may have contained 
impurities which could have poisoned the catalyst. The 
crude anhydride was prepared from 2-naphthoic acid using a 
large excess of acetic anhydride and a catalytic amount of 
sulphuric acid. 
Considering the difficulty of obtaining 2-naphthoic 
anhydride sufficiently pure, and the poor literature yield 
(13%) for the synthesis of (20), this approach was not 
pursued further. 
The possibility of using a Robinson ring closure as 
the key step for the preparation of 13-hydroxymethyl 
dibenzo(a,c)fluorene (21) was also investigated. 	The 
approach we adopted is outlined in Scheme 14. 	An 
important intermediate is ketone (22) but the synthesis of 















1) BuLi, ether ii)Me 2 S.CuB, cuprate iii)..rc,OEt, Michael 
addition iv) Cyclisation v) Reduction vi) Aromatisation vii) 
Base, HCHO Scheme 14 
9-Bromophenanthrene was first converted to 9-
phenanthrenyl lithium (23) by treatment with BuLi in 
Et 20127 . The corresponding lithium organocuprate reagent 
was then generated according to the methodology described 
by House et al. 128 . A Michael addition with ethyl 
acrylate was then attempted at several temperatures 
between -65°C and room temperature but unfortunately the 
required product (24) could not be obtained (Scheme 15). 













oJ' COOEt  
(24) 
Scheme 15 
It is possible that the phenanthrenyl cuprate reagent 
was not generated in situ, because of steric hindrance. 
This approach was also abandoned. 
Finally, the procedure by Hopkinson et al. 129 for the 
synthesis of benzofluorenés via the rearrangements of a-
alkoxycarbonyldiarylmethyl cations was examined (Scheme 
16). This method enables 13-methoxycarbonyldjbenzo(a,c) 

















If this compound (26) could be reduced, this approach 
would provide a facile synthesis of the required alcohol 
(21). 
The synthesis of methyl (phenanthren-9-yl, phenyl) 
glycolate (25) was carried out in ether by reaction 
of 9-phenanthrenyl lithium (23) with methyl benzoyl- 
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fox-mate. Treatment of (25) under acidic conditions (conc. 
H 2 S0 41 CH 3 COOH at 10°C) led to the formation of (26) in 
poor yield. The major product was the lactone (27) (46%) 
(the formation of which may be rationalised by 4ir-electro--
cyclisation of the carbonium ion shown in Scheme 17). 
C5H5 	 ri 
_OCH3 	
iHydroysis 
Scheme 17 	 (27) 
These results are in agreement with those described in 
the literature. 
In an attempt to improve the yield of the reaction, 
polyphosphoric acid (PPA) was tried as an alternative 
catalyst. Surprisingly, treatment of (25) with PPA at 
110°C, led to the formation of the desired ester (26) in 
42% yield. The lactone (27), in this case, was a minor 
product (11%). 
The reduction of ester (26) proved difficult. The use 
of excess (3 equiv.) LiA1H 4 at 0°C did not give the 
expected alcohol (21), whereas LiBH 4 gave a trace of the 
desired product, which could not be isolated. 'H n.m.r. 
showed the presence of 13H-dibenzo(a,c)fluorene (15) 
(singlet at 3.9 ppm corresponding to the CH 2 ) and also the 




Two further attempts using NaBH 4 in a large excess (5 
to 16 equiv.) in a methanol-dichloroinethane mixture were 
unsuccessful. The reduction was finally achieved in 48% 
yield using three equivalents of diisobutylaluininjum 
hydride (DIBAL-H) in dichioromethane at -50°C. 
This 	last 	route 	provided 	a 	synthesis 	of 
13-hydroxymethyldjbenzo(a,c)fluorene (21) in four steps 
with an overall yield of 10%. 
The acetate of both the alcohol (21) and 9-fluorene-
methanol were then prepared in order to compare their 
behaviour on an HPLC column packed with PGC. 
9-Fluorenylmethy]. acetate (29) gave a retention time 
of 3.3 mm (eluted with CHC1 3 ), whereas 13-acetoxymethyl 
dibenzo(a,c)fluorene (30) under the same conditions, was 










These results were encouraging. 	However, 	in an ideal 
situation the compound would be totally retained. Hence 
modification of alcohol (21) was required. 
A bigger and symmetrical compound (31) was designed by 
adding two more aromatic rings on (21), to both improve 
the retention on the column and avoid the problem of a 
chiral centre at C(13), which could complicate 




2.2 SYNTHESIS OF TETRABENZOFLIJORENES AND DERIVATIVES 
2.2.1 Synthesis of 1 7-Hydroxv]nethyjtetrabenzo(a,c,g,j) 
f]uorene 
The tetrabenzofluorenyl alcohol (31) was prepared in a 
way analogous to that described for the dibenzo derivative 
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(a) BuLi, Et 20, r.t., 30 mm; EtOOCCOOEt, Et 20, 0°C-5 0C, 
2h, 63%; (b) 9-Broxnophenanthrene, BuLl, Et 20, r.t., 
30 mm; (32), Et 20, 0°C-5°C, 2h, 46%; (C) PPA, 140°C, 4h, 
49%; (d) DIBAL-H (3 equiv.), CH 2 C1 2 , -65°C, lh, 73%. 
Scheme 18 
Initially the direct synthesis of compound (33) from 
9-phenanthrenyl lithium (23) (obtained upon treatment of 
9-bromophenanthrene with BuLi in ether 127) was attempted. 
Reaction of 2 equivalents of the lithium salt with 1 
equivalent of diethyl oxalate, gave a mixture of products 
from which the expected tertiary alcohol (33) could not be 
isolated. 
Fortunately, synthesis and isolation of the a-keto 
ester (32) was possible. This was achieved by adding 9-
phenanthrenyl lithium to a solution of diethyl oxalate 
(20% excess) in ether at 0°C. The reaction mixture was 
subsequently heated under reflux for 2 hours. Following 
purification by flash chromatography, the product was 
isolated in 23% yield. 
In an attempt to improve the yield of this reaction, 
tetrahydrofuran (THF) was tried in place of ether as the 
solvent. 
In THF a clear orange solution of 9-phenanthrenyl 
lithium was obtained and the subsequent reaction in THF 
with diethyl oxalate gave a complex mixture, in which the 
major product was found to be 9(1 1 -butyl)-phenanthrerie 
(10%). 
An explanation of these results might be that 9-
phenanthrenyl lithium (23) forms a precipitate when the 
reaction is carried out in ether, and this allows the by-
product, n-butyl bromide, to be almost entirely removed by 
(flflRf C. flflR+ 
-H° - Electrocyclisot ion 
(3Z.) 
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syringe127 . 	This precaution reduces the competing 
reaction of 9-phenanthrenyl lithium with n-butyl bromide, 
which results in the formation of 9(1 1 -butyl)-
phenanthrene. 
The best synthesis of (32) was finally achieved in 
ether, by carefully adding 9-phenanthrenyl lithium to a 
solution of diethyl oxalate (20% excess), between 0°C and 
5°C, and subsequently stirring the reaction at room 
temperature (63% yield). 
The tertiary alcohol (33) was then synthesised in 
adequate yield (46%) under similar conditions using (32) 
as the keto ester component. 
Treatment of (33) with polyphosphoric acid at 140°C 
led to the formation of the cyclic ester (34) in 49% yield 
via 4T-electrocyclisation of the a-ethoxycarbonyl diaryl 
cation (Scheme 19). 




Purification of (34) proved difficult, due to the 
formation of side products whose structures have not been 
identified. Recrystallisation of the crude material 
following flash chromatography, was not sufficient to give 
completely satisfactory analytical results (cf: elemental 
analysis and infrared spectroscopy). A small peak at 1810 
cm' compatible with a a,-unsaturated lactone could be 
detected in the IR spectrum. 
The modified procedure developed by Eaton et al. 130 , 
for general cyclisation of this type, involved the use of 
a 1:10 phosphorus pentoxide - methanesulphonic acid 
solution in place of polyphosphoric acid. However, under 
these conditions, the cyclisation of the tertiary alcohol 
(33) was unsuccessful; at room temperature no reaction 
occurred, and upon heating at 90-100°C for lh, a black 
polymer was formed yet again. 
Reduction of ester (34) to the corresponding alcohol 
(31) proceeded in a straightforward manner (73% yield). 
Interestingly, a trace of the aldehyde could be detected. 
This was confirmed by mass spectrometry: m/z (El) 394(M+, 
100), 365(M+..CHO, 30), 178(48). The reaction was carried 
out in DCI'! at -65°C using 3 equivalents of DIBAL-H. 
Following flash chromatography and recrystallisation 
from DCI'!, crystals of (31) were obtained and proved 
suitable for X-ray analysis. 
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The crystal structure of alcohol (31) reveals several 
interesting features (Fig. 3a and Fig. 3b). It indicates 
that there are two molecules held together by hydrogen 
bonding between the two hydroxyl groups. The exocyclic 
hydroxymethyl group has two different conformations, 
probably as this is required for the formation of the 
hydrogen-bonded dirner. The interaction between H. and H. 
(d = 2.03 A, Van der Waal's radius for hydrogen = 1.2 A) 
is responsible for the degree of non-planarity in the 
molecule. 
This molecule is chiral if it adopts a fixed 
orientation, as in the crystal structure. Therefore it is 
possible that in solution at low temperature, the molecule 
may also adopt a fixed orientation and be chiral. 'H 
n.m.r. at room temperature in CDC1 3 showed a triplet (o = 
5.05 ppm) as well as a doublet (o = 4.5 ppm), 
corresponding to H(17) and the two protons of the 
methylene group respectively. A probable explanation is 
that the phenanthrene rings can oscillate rapidly during 
the acquisition period and consequently the protons of the 
CH 2 group are magnetically equivalent (as are the matched 
pairs of aromatic protons, e.g. H(2) and H(15). 
Nuclear Overhauser experiments carried out on this 
compound showed the close through-space interactions 
between the methylene group and the two aromatic protons 
H(1) and H(16). 
Fig. 3. X-ray crystal structure, (a) 'side' view of (31) 
showing the unit cell. 
Fig. 3. x-ray crystal structure, (b) 'overhead' view of 
(31). 
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• Finally, 	17-acetoxymethyltetrabenzo(a,c,g, 1) fluorene 
(35) was easily prepared in 80% yield from alcohol (31) 
using a large excess of acetic anhydride and a catalytic 




As expected, the acetate (35) was totally retained 
when passed through an HPLC column packed with PGC (eluent 
CHC1 3 ) 131 whilst under the same conditions 13-acetoxy-
methyldibenzo(a,c)fluorene (30) was slowly eluted. 
These results were considered to be satisfactory, and 
hence the possibility of linking alcohol (31) to an amino 
acid via the chioroformate or the N-succinimidyl carbonate 
was investigated. 
2.2.2 Synthesis of Tbfmoc Glv OH 
Preparation 	of 	Na_17_tetrabenzo(a,c,g, i) fluorenyl- 
methoxycarbonyiglycine (Tbfmoc Gly OH) (36) was first 
examined via the aryl chloroformate (37). 
Unfortunately, reaction of the tetrabenzofluorene 
alcohol (31) with phosgene in the presence of a strong 
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base such as triethylainine or N -methyl2morpholine led to 
the formation of the olefin (38) as the major product 
(indicated by a singlet at 6.9 ppm by 'H n.m.r. 





(37) 	 (38) 
The possibility of repeating the reaction using, this 
time, a weaker base such as N,N'-dimethylanj]jne (pKa = 
5.15)132 was then investigated. Under these conditions, 
the desired product could be obtained in situ (reaction 
followed by IR) together with the hydrochloride salt of 
the base and a trace of the olef in. 
However, purification by chromatography or aqueous 
work-up to remove the hydrochloride salt remained 
unsuccessful, due to the instability of this compound in 
solution with respect to water and base. 
The chioroformate (37) was finally synthesised by the 
following sequence of reactions: treatment of alcohol (31) 
with N,N'-bis-trimethylsilyl urea (2.5 equiv) to give the 
corresponding trimethylsily]. ether (39), followed by 
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reaction of the latter with phosgene. 	Following 
recrystallisation, the pure product could only be obtained 





ral '1 tail 
(31) 	 (39) 	 (37) 
(a) N,N'-bis-trimethylsjlyl urea (2.5 equiv) ., CH 2C1 2 , 
reflux, 3h, 81%; (b) phosgene (7.5 equiv), CH 2C1 2 , reflux, 
2h, 21%. 
Scheme 20 
In view of the problems of purification and the 
instability of the chioroformate (37), the synthesis of 
the more stable N-succininiidyl carbonate (40) was 
undertaken. 	The chioroformate generated as above, was 
reacted in situ with one equivalent of each 	N-hydroxy- 
succinimide and N,N'-dimethylani].jne. 	Isolation of the 
carbonate (40) involved first an aqueous work-up 
procedure, followed by purification by flash 








C-NHCH 2 COO(CH 3 )3 -NHCH 2COOH 
(42) Tbfmoc GEyOH (36) 
(c) 
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However, it was not possible to separate the carbonate 
(present in 37% yield) from unreacted N-hydroxy-
succiniinide. 
Tbfmoc Gly OH was finally synthesised in three steps 
from alcohol (31) via the p-nitrophenyl carbonate (41) as 
depicted in Scheme 21. 
OH 
1  0 0 0 - ( a) 0 0 (31) 
para-Nitrophenyl chioroformate (2 equiv), N,N'-
dimethylaniline (1 equiv), CH 2 C1 2 , r.t., 	72h, 80%; 
CH 3 COOH • NH 2 CH 2 COOC(Ne) 3 , 	N,N'-dimethylaniline 	(2 
equiv), CH 2 C1 2 , r.t., 24h, 79%; (c) para-toluenesulfonjc 
acid (0.3 equiv), CH 2 C1 2 , reflux, 5h, 90%. 
Scheme 21 
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Reaction of commercially available para-nitrophenyl 
chloroformate (2 equiv) with alcohol (31) and N,N'-
dimethylaniline gave the mixed carbonate (41) in 80% 
yield. This material was in turn reacted with the acetate 
salt of glycine tert-butyl ester in the presence of two 
equivalents of N,N'-dimethylaniline to afford the 
protected glycine tert-butyl ester (42) (79%). Simple 
hydrolysis of the latter using p-toluenesulphonic acid in 
refluxing DCM gave the desired acid (36) in 90% yield. 
This provided an easy synthesis of Tbfmoc Gly OH using 
mildly basic conditions in a 57% overall yield based on 
alcohol (31). 
2.3 APPLICATION TO THE SYNTHESIS AND PURIFICATION OF 
PEPTIDES 
2.3.1 Synthesis of Fmoc Glv Ser Met Val Leu Ser OH 
This peptide was readily available in our laboratory 
and was selected as the first test peptide. 
The protected resin-bound peptide Fmoc Ser (OtBu) Met 
Val Leu Ser (OtBu) (43) was prepared on the peptide 
synthesiser using an orthogonal strategy 133 . Fmoc was 
used for the temporary protection of the amine function of 
each amino acid and was removed before each coupling with 
a 20% piperidine in DMF solution. The side-chain function 
of serine was protected with the t-butyl group. The 
coupling procedures involved a symmetrical anhydride 
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followed by an HOBt ester coupling. Acetic anhydride and 
pyridine were used to acetylate any unreacted amino 
functions. The Merrifield resin was employed with the 
p-alkoxybenzylalcohol group as the linker. 
Fmoc Gly Ser Met Val Leu Ser OH (44) was synthesised 
from the resin-bound peptide (43) via the series of 
reactions outlined in Scheme 22. 
t-Bu 	 t-Bu 
Fmoc-Ser-Met-Val -Leu-Ser 
(43) 
Deprotection 	 20% piperidine/DMF 
V 
t-Bu 	 t-Bu 
I I 
'' 2 -Ser-Met-Val-Leu-ser-( 
Fmoc Gly OH (6 equiv)/ Coupling 	
DIC (3 equiv), 
dioxan, 5h, r.t. 
V 
	
t-Bu 	 t-Bu 
I I 
Fmoc, Gly-Ser-Met-Val-Leu-ser-I 





After deprotection of the Fmoc group under basic 
conditions the amino-terminus of the peptide was coupled 
in dioxan to Fmoc Gly OH via its symmetrical arthydride (3 
equiv) with a coupling efficiency of 88%. cleavage of the 
hexapeptide from the resin and removal of the t-butyl 
groups was carried out using TFA, and in the presence of 
ethY]fmethYl(sulPhide and anisole as cation scavengers. 
After removal of the solvent in vacuo the peptide was 
finally precipitated with ether, filtered of f and dried. 
Purification of the peptide was difficult. Removal of 
the scavengers by gel filtration (Sephadex Gb, 30% acetic 
acid) was not possible as it was insoluble in aqueous 
media. Purification using HPLC was then considered, and 
for that purpose the best solvent was found to be dioxan 
in which the peptide was soluble at approximately 
1.5 mg/nd. Preparative HPLC gave the peptide (44) 
together with a trace of the sulfoxide derivative, as 
indicated by mass spectrometry (MH+16). The identity of 
the peptide was confirmed by mass spectrometry and amino 
acid analysis. 
2.3.2 Synthesis of Tbfmoc Gly Ser Met Val Leu Ser OH 
Tbfmoc Gly Ser Met Val Leu Ser OH (45) was then 
prepared from the resin-bound peptide (43) via a similar 
method. 
Tbfmoc dy OH was coupled in dioxan with an 80% 
coupling efficiency. 	Removal of the peptide from the 
resin and t-butyl cleavage were carried out with TFA in 
the presence of the same scavengers. The peptide was 
finally precipitated with ether, filtered off and dried 
(69% yield). 
As before, purification proved difficult. 	Also, a 
fresh solution of the crude peptide in dioxan gave one 
peak on HPLC, but on standing (30 mm) the same solution 
gave two peaks corresponding to the desired peptide and 
the sulfoxide derivative. After isolation of these two 
peptides by preparative HPLC, these assignments were 
confirmed by mass spectrometry (MH+ and MH+16+) and amino 
acid analysis. 
The facile oxidation of methionine to the sulfoxide 
might be due to the presence of peroxides in the dioxan 
used to dissolve both the Fmoc and Tbfmoc peptides. 
However, this does not explain why the corresponding Fmoc 
peptide was not oxidised at the same rate. 
2.3.3 Behaviour of Tbfmoc and Fmoc Derivatives on PGC 
The retention of both Fmoc Gly OH and Tbfmoc Gly OH 
was compared on a column packed with graphitised carbon. 
A solution of Fmoc Gly OH (10.2 mg, 34.3 tmole) in 
dioxan was loaded on a 6 mm diameter column packed with 
PGC (1.5 g). Only 15 ml of dioxan was required to elute 
the compound completely (as monitored by t.l.c.). In 
contrast, when Tbfmoc Gly OH (10.2 mg, 20.5 mole) was 
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loaded under the same conditions, none of this material 
was eluted in the first 35 ml. Indeed the total volume of 
dioxan needed to elute the compound was 300 ml. 
The behaviour on a graphitised carbon column of Fnioc 
Gly Ser Met Val Leu Ser OH (44) was then compared with the 
Tbfmoc derivative (45). To increase the overall retention 
time, a mixture of dioxan/water (2:1) was used to elute 
both peptides. After loading a solution of the Fmoc 
hexapeptide (9.2 mg, 11.3 tmo1e) in a mixture of dioxan/ 
water (2:1) onto the column, the peptide was eluted 
completely with 75 ml of the solvent mixture. In 
contrast, the Tbfmoc derivative (10.5 mg, 10.3 mole) was 
not eluted at all in the first 80 ml of solvent and was 
subsequently only very slowly eluted from the column. 
As these results were promising, the deprotection of 
the Tbfxnoc group from the peptide, while still retained on 
the graphitised carbon column was investigated. 
The best results were obtained when the deprotection 
was carried out using 20% piperidine in a mixture of 
dioxan/water (2:1). 	Under these conditions the Tbfmoc 
hexapeptide was totally deprotected. 	The free peptide 
(HGly Ser Met Val Leu Ser OH (46)) was eluted and was 
monitored by t.l.c. using ninhydrin to reveal the amino 
function. The subsequent isolation of the product was 
simple; the piperidine and solvents were removed in vacuo 
and the peptide was precipitated with ether, filtered and 
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dried (85%). Mass spectrometry showed both the presence 
of the peptide (MH) and the sulfoxide derivative (MH + 
16+). Amino acid analysis confirmed the composition of 
the peptide. 
Finally, the tetrabenzofluorene olef in (38) or its 
piperidine adduct, the by-products from the deprotection 
step, were removed from the column by eluting with hot 
dioxan. 
Considering the good degree of retention shown by the 
small Tbfmoc hexapeptide (45), this purification method 
was ready for testing on larger peptides. 
2.3.4 Synthesis of Fmoc Ubiquitin (54-76 OH 
Ubiquitin is a protein of 76 amino acids and its 
synthesis is currently being undertaken in our laboratory. 
Consequently fragments of ubiquitin were selected as more 
challenging peptides. 
The resin-bound peptide Fmoc ubiquitin (54-76) (47) 
was prepared on the peptide synthesiser 134 under the 
conditions described in section 2.3.1 (for the protection 
of side-chain functional groups (see Section 1.1.6)). 
Most coupling procedures involved a symmetrical anhydride 
followed by an HOBt ester coupling in a mixture of DMF/ 
dioxan (1:1) as the solvent. 
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2.3.5 Synthesis of Tbfmoc Ubiquitin (53-76) OH 
Tbfxnoc ubiquitin (53-76) OH (48) was synthesised from 
the resin-bound peptide (47) as depicted in Scheme 23. 
Fmoc ubiquitin*  (54-76) 
 
Deprotection 	 20% piperidine in DMF 
NH 2 ubiquitin*  (54-76) 
Coupling 	 Tbfmoc Gly OH/DIC/HOBt 
Tbfmoc ubiquitin*  (53-76) 
Deprotection 	 TFA/scavengers I 
Tbfmoc ubiquitin* (53-76) OH 
 
* : amino acid side-chains protected. 
Scheme 23 
The resin-bound peptide Fmoc ubiquitin (54-76) was 
initially trated with a mixture of acetic anhydride/ 
pyridine (1:1) in order to cap any amino functions. After 
deprotection in basic conditions the peptide was coupled 
in dioxan to Tbfmoc Gly OBt ester (4 equiv), generated in 
situ from DIC and HOBt, with a coupling efficiency of 88%. 
After final cleavage using TFA in the presence of anisole 
and thioanisole as cation scavengers, the Tbfmoc ubiquitin 
peptide (48) was precipitated with ether (96% yield). 
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2.3.6 Behaviour of Na_Acetyl_Ubiauitin (54-76) OH and 
Tbfmoc Tjbiauitin (53-76) OH on PGC 
Na_Acetyl_ubiquitin (54-76) OH (49) was prepared from 
the resin-bound peptide (47) by the following reactions. 
Deprotection of the Fmoc group from the peptide using 
20% piperidine in DMF. gave the peptide with a free N-
terminal amino group, which was then acetylated with a 
mixture of acetic anhydride/pyridine (1:1) (100 equiv). 
Removal of the peptide from the resin and cleavage of the 
side-chain protecting groups were carried out using TFA in 
the presence of anisole and thioanisole as scavengers. 
Subsequent precipitation with ether afforded crude N_ 
acetyl-ubiquitin (54-76) OH (49). 
The behaviour of both the Na_acetyl and Tbfmoc 
ubiquitin peptides on a PGC column was then examined. 
In a typical experiment a solution containing 5 ing of 
each peptide was loaded onto the column which was then 
eluted using different solvent mixtures. After collecting 
the fractions, the solvent was removed in vacuo and the 
residue obtained was redissolved in fresh solvent before 
analysis by HPLC. 
Initially, a 10% aqueous solution of acetic acid was 
used as the eluerit, but in this system, neither peptide 
was sufficiently soluble and both were slowly eluted. No 
separation was achieved. The same results were observed 
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when a mixture of MeOH/H 20 (1:1) was tried. 	The best 
results were obtained when a mixture of CH 3CN/H 20 (1:1) 
was used. Under these conditions, the Na_acetyl_peptide 
was eluted completely by 30 ml of the mixture, whereas the 
Tbfmoc peptide was retained. 
The total chromatographic separation of these closely 
related peptides clearly demonstrated the efficiency of 
the method and its potential for the purification of 
peptides synthesised by solid phase methodology, provided 
careful attention is paid to the choice of solvents. 
As these results were promising, the technique was 
used in the purification of ubiquitin (53-76) OH (50), and 
subsequently extended to a second N-terminal glycine 
peptide, ubiquitin (35-76) OH (51). 
2.3.7 Purification of Ubiauitin (53-761 OH 
A simple chromatographic elution on a column packed 
with graphitised carbon was used as the first purification 
step (as described in Section 2.3.6). Crude Tbfmoc 
ubiquitin (53-76) OH (48) dissolved in a mixture of 
CH 3 CN/H 20 (1:1; 0.5% TFA) was loaded onto a column packed 
with PGC (50 x mass of peptide). 50 nil of a mixture of 
the same solvent was required to completely elute the main 
/ impurities (probably Na_acetyl ubiquitin (5_76) and 4 
unreacted ubiquitin (54-76)). None of the Tbfmoc peptide 
r1 
was eluted even after flushing the column with a further 
50 ml of CH 3 CN/H 20 (1:1). Deprotection of the Tbfmoc 
group was carried out using 20% piperidine in a mixture of 
CH 3 CN/H 20 (1:1) and only the desired peptide, ubiquitin 
(53-76) OH, was eluted. After removal of the solvent in 
vacuo, the peptide was finally precipitated with ether. 
Subsequent purification by preparative HPLC gave pure 
ubiquitin (53-76) OH (50) in 15% overall yield (see Fig. 
4) 
The identities of both Tbfmoc ubiquitin (53-76) OH and 
ubiquitin (53-76) OH peptides were established by high 
resolution mass spectrometry and amino acid analysis. 
2.3.8 Synthesis and Purification of Ubiguitin (35-76 
The purification of this peptide did not pose any 
problems and was carried out as with the smaller ubiquitin 
fragment (50); Tbfmoc ubiquitin (35-76) OH (52) was 
prepared by coupling in situ Tbfmoc Gly OBt to the resin-
bound peptide ubiquitin (36_76)135 (75% yield). Following 
chromatography on a PGC column and preparative HPLC, the 
desired peptide (51) could be obtained (see Fig. 5). 
The authenticity of (51) was also confirmed by mass 
spectrometry and amino acid analysis, and its purity by 
analytical HPLC. 
2.4 PREPARATION OF OTHER TBFMOC A14INO ACIDS 
Initially, the potentiality of directly linking the 
I 
"liii' 'ill. I 
mu 
'Hill' 
Crude Fmoc Ubiquitiri 	 Crude Tbfinoc Ubiguitin 
(54-76) OH (47) 
	
(53-76) OH (48) 
Fig. 4. Analytical HPLC: column ABI, aquaporeODS-300, C-18 1 
300 A pore size, 7 tIm spherical silica (220 x 4.6 mm) 
solvents: A(H 2 0/TFA (0.1%)), B(CH 3 CN/TFA (0.1%)) 
conditions: A(90%) 25 lfli.fl > A(10%); X=214 mn; AUFS=1 
flow rate: 1 mi/mm. 
Crude Ubiquitin 	 Purified Ubiquitin 
(53-76) OH (50) (53-76) OH (50) 
(after PGC column chromatography) 
	
(after preparative HPLC) 
Fig. 4. Analytical HPLC: column ABI, aquaporeODS-300, C-18, 
300 A pore size, 7 pm spherical silica (220 x 4.6 mm) 
solvents: A(H 20/TFA (0.1%)), B(CH 3 CN/TFA (0.1%)) 
conditions: A(90%) 	 A(10%); X=214 nm; AUFS=1 
flow rate: 1 mi/mm. 
1 	 2 	 3 
Crude Tbfmoc Ubiquitin (35-76) OH (52) 
Crude Ubiquitin (35-76) OH (51)after PGC column chromatography 
Purified Ubiquitin (35-76) OH (51) (after preparative HPLC) 
Fig. 5. Analytical HPLC: column ABI, aquaporeODS-300, C-18, 
300 A pore size, 7 tm spherical silica (220 x 4.6 nun) 
solvents: A(H 20/TFA (0.1%)), B(CH 3CN/TFA (0.1%)) 
conditions: A(90%) 25 nun > A(10%); X=214 nxn; AUFS=1 
flow rate: 1 mi/mm. 
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Tbfmoc group to a resin-bound peptide via the p-nitro-
phenyl carbonate or the chloroformate was investigated. 
Coupling of the mixed carbonate (41) (three to five 
equivalents either in dioxan or Dc?'! in the presence of one 
'equivalent of N,N'-diinethylaniline) to the resin-bound 
peptide ubiquitin (36-76), did not afford the 
corresponding Tbfxnoc peptide. The major products were 
found to be the olef in (38) and p-nitrophenol, as judged 
by t.l.c. of the filtrate. 
In the case of the chloroformate (37), generated in 
situ as described in Section 2.2.2 and coupled in large 
excess (10 equiv), the reaction with either ubiquitin 
(54-76) or ubiquitin (36-76) resin-bound peptides, 
resulted in low coupling efficiencies (17% and 25% 
respectively). 
As described in Section 2.2.2, and illustrated with 
Tbfmoc Gly OH, the alternative approach is synthesis of 
the peptide less its N-terminal amino acid, and a final 
coupling of this amino acid previously protected with the 
Tbfmoc group. 
This necessitates the preparation of a range of Tbfmoc 
amino acids. 
2.4.1 Synthesis of Tbfinoc-L-Phe OH 
Preparation of this compound proved difficult. 
The free amine function of commercially available L-
phenylalanine tert-butyl ester hydrochloride was initially 
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liberated with triethylainine. The amine in 20% excess was 
then reacted with the mixed carbonate (41) in the presence 
of N,N'-dimethylaniline. However, after removal of the t-




0 0 0 
.0 0 
The formation of (53) may be rationalised by - 
elimination of the mixed carbonate (41), 1,2 addition of 
the amino ester onto the resulting olefin (38) and finally 
cleavage of the t-buty]. ester. 
As the acetate of glycine was successful in the 
synthesis of Tbfmoc Gly OH, this method may also be useful 
in this case; thus the acetate salt of L-phenylalanine 
tert-butyl ester was prepared. 
The hydrochloride salt of the amino acid ester was 
neutralised with triethylamine and the precipitated 
Et 3N.HC1 generated was filtered of.  f. Following removal of 
the solvent, the residue obtained was redissolved in 
acetic acid before lyophilisation. Subsequent reaction 
with the mixed carbonate (41) in the presence of two 
equivalents of N,N'-diniethylaniline afforded Tbfmoc-L-Phe 
MI 
OtBu (54) in 46% yield after purification by flash 
chromatography and recrystallisation. Final cleavage of 
the t-butyl ester using a mixture of TFA/H 20 (95:5) gave 
Tbfmoc-L-Phe OH (55) in excellent yield. 
A possible drawback of the method is the first step. 
Due to the insolubility of L-phenylalanine t-butyl 
ester hydrochloride in ethyl acetate, neutralisation with 
triethylamine fails to reach completion, even after a long 
period. Thus, the precipitate which is largely triethyl-
amine hydrochloride also includes some unreacted 
L-phenylalanine t-butyl ester hydrochloride (as judged by 
t.l.c.). This explains the significant losses of material 
encountered after lyophilisation. This method has the 
advantage, however, of eliminating any traces of 
triethylamine present in the filtrate. 
2.4.2 Attempted Syntheses of Tbfmoc-L-Met OH 
Methionine was the next target as this amino acid 
often forms the N-terminal residue of numerous 
biologically active peptides and proteins. 
Kricheldorf's method136 for the preparation of a-amino 
acids, based on silicon chemistry, was examined first. 
L-methionine was treated in DC)! with two equivalents of 
both chiorotrimethylsilane and triethylamine to give N-
trimethylsilylmethionine trimethylsilyl ester. Subsequent 
reaction of the latter with chloroformate (37) followed by 
rI, 
aqueous work-up led, however, to the formation of several 
products. 1 H n.m.r. and mass spectrometry did not show 
the presence of the expected compound. 
Another attempt involved the use of resin-bound 
methionine. 9-Fluorenylxnethoxycarbonyl-L-methionine was 
coupled to the p-alkoxybenzylalcohol resin via its 
symmetrical anhydride in the presence of a catalytic 
amount of 4-dimethylaminopyridine. Following deprotection 
of the Fluoc group, the free amino function was reacted 
with chloroformate (37) under the conditions described 
above. Unfortunately, the reaction gave a very low 
coupling efficiency (8%). 
Both of these approaches were abandoned. 
In an approach similar to that described in section 
2.4.1, methionine methyl ester was treated with the mixed 
carbonate (41) in the presence of base, and the desired 
compound, Tbfiuoc-L-Met OCH 3 (56) was obtained in 53% 
yield. Complete hydrolysis of the methyl ester required 
the use of HBr in aqueous acetic acid at 60°C for 5h. 
Under these rather severe conditions, only a poor yield of 
Tbfmoc-L-Met OH could be obtained. 
The difficulties encountered in the hydrolysis of the 
methyl ester indicated that this route was not viable 
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either, and was therefore abandoned. 
Synthesis of Tbfmoc-L-Met OH should be possible and is 
worth exploration in the future through the use of L-
inethionine tert-butyl ester. Unfortunately, it is not 
commercially available. Preparation of this compound has 
been described in the literature from Na_phthalyl_L_ 
methionine, 2-methyipropene and a catalytic amount of 
sulphuric acid137 . 
2.5 CONCLUDING REMARKS 
The efficiency of this new method of purification has 
been clearly demonstrated for the purification of 
N-terminal glycine peptides prepared by solid phase 
methodology. 
Although the coupling of other Tbfmoc amino acids 
(such as Tbfnioc-L-Phe OH) to a resin-bound peptide have 
not been tried, this should be possible via their 
symmetrical arthydrides or HOBt esters. 
The properties of the Tbfmoc group could also be used 
advantageously in different areas of peptide and protein 
chemistry. 
It could be employed as a fluorescent label (see 
Appendix I : excitation wavelength : 383 nm; emission 
wavelength : 424 nm), particularly in immunology, where 
detection of compounds present in very low concentrations 
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requires highly sensitive techniques. 
The strong affinity of the Tbfmoc group for 
graphitised carbon could also be applied in other fields 
of organic chemistry. 
One such example is the resolution of racemates. 
2.6 APPLICATION TO THE RESOLUTION OF RACEMATES 
2.6.1 Introduction 
Ligand-exchange chromatography (LEC) was developed by 
Davankov and Rogozhin in 1971 138 . It involves the 
reversible formation of complexes between a central metal 
ion (usually Cu2+ and Ni 2+) and two chelating chiral 
bifunctional molecules (typically a-amino acids) 139 . 
When the chelators are a-amino acids, both the amino 
and the carboxylate groups of the two chelators 
participate in the formation of the complexes. If one of 
the chiral chelators is immobilised on an inert support to 
provide a chiral stationary phase, a mixture of 
enantiomers added in an analyte will bind to give a pair 
of diastereoi-someric complexes, each with two bidentate 
ligands. 
The difference between the relative stabilities of the 
diastereoisomeric adsorbates is responsible for the 
chroinatographic separation of the enantiomers. 
The strong affinity of the 17-tetrabenzo(a,c,g,i)- 
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fluorenylinethyl (Tbfm) group for graphitised carbon 
suggested to us a possible use in that particular field. 
Indeed, an optically active amino acid could be linked 
to the Tbfm group to provide a chiral chelator, and a PGC 
column could easily be used to provide a support for it. 
Alanine was initially chosen as the chiral chelator 
because of its simplicity. 
2.6.2 Synthesis of Tbfm-L-Ala OH 
This work was done in parallel with the development of 
the purification method (see section 2.3). Although Tbfm-
L-Phe OH (53) was obtained as the major product during the 
synthesis of Tbfmoc-L-Phe OH (55), the structure of this 
compound had not been elucidated when this work on the 
resolution of racemates was started. 
A number of routes to Tbfm-L-Ala OH (57) were 
explored. 
Initially the synthesis of this compound via the 
addition of the amino acid onto the tetrabenzofluorene 
aldehyde (58) was investigated as outlined in Scheme 24. 
ox. L-AIa 
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(31) 	 (58) 






(59) 	 (57) 
Scheme 24 
Careful oxidation of alcohol (31) should give aldehyde 
(58), which in turn, could be reacted with L-alanine to 
give the intermediate iinine (59). Reduction of the latter 
using H 2/Pd on charcoal or NaBH 3CN could provide 
Tbfm-L-Ala OH. 
Unfortunately, synthesis of aldehyde (58) was not 
straightforward. The following reagents were used in an 
attempt to oxidise alcohol (31) to the corresponding 
aldehyde: 
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- pyridinium dichromate (PDC) 140 (1.5 equiv/CH 2 C1 2/r.t.) 
- pyridinium chlorochromate (PCC) 141 (1.5 equiv/CH 2 C1 2/ 
r.t.) 
- Swern oxidation 142 (DMSO/oxalyl chloride/Et 3N/CH 2 C1 2/ 
-50°C) 
- tetrapropylainmonium perruthenate 143/4-xnethylmorphol me 
-4 oxide/CH 2 C1 2/r.t. 
In all cases a complex mixture of products was 
obtained. 
Only under the conditions of the Swern oxidation could 
the aldehyde be detected. This was indicated by n.m.r. 
(singlet at 10.5 ppm) and infrared spectroscopy peak at 
1670 cm'). 
A second approach involved reduction of 17-ethoxy-
carbonyltetrabenzo(a, c,g, i) fluorene (34) using one 
equivalent of DIBAL-H at -100°C in DCN or toluene. 
Under these conditions, however, alcohol (31) was 
obtained as the major product. In view of the problems at 
the aldehyde stage this route was abandoned. 
Finally, in a third approach, the amino acid was 
successfully reacted with the mesylate derivative (60) and 
this provided an alternative route to the synthesis of 



















MINI f10  ,oci
(61) 	 (57) 
(a) Nethanesulfonic anhydride (10.5 equiv), N,N'-dimethyl-
aniline, (2.5 equiv), CH 2 C1 2 , r.t., overnight, 76%; (b) L-
Ala t-butyl ester. HC1 (2 equiv), Et 3N (2 equiv), EtOAc, 
r.t., 3h; (60) (1 equiv), N,N'-dimethylaniline (1 equiv), 
EtOAc, r.t., overnight, 76%; (C) TFA/H 20 (95:5, r.t., 
3.5h, 69%. 
Scheme 25 
Preparation of inesylate (60) from alcohol (31) was 
initially carried out using inethanesulfonyl chloride. Due 
to the low reactivity of alcohol (31) it was necessary to 
heat the reaction at 60°C for 4h in methanesuiphonyl 
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chloride (solvent) and N,N'-dixnethylaniline (4 equiv). 
Even under these conditions, the inesylate could only 
be obtained in 32% yield. The major side products were 
found to be the olefin (38) and methanesulfonic acid. In 
an attempt to improve the yield of the reaction, an 
alternative reagent, inethanesulfonic anhydride, was tried. 
Using a large excess of inethanesulfonic anhydride (10.5 
equiv) and N,N'-diinethylaniline (2.5 equiv) in 
dichloroinethane, the mesylate (60) was finally obtained in 
76% yield. 
The remaining reactions proceeded in a straightforward 
manner. L-Lanine tert-butyl ester hydrochloride was 
liberated as the free amine with one equivalent of 
triethylamine in ethyl acetate, and reacted with mesylate 
(60) in the presence of N,N'-dimethylaniline (1 equiv), to 
give the protected L-alanine tert-butyl ester (61) (76% 
yield). Simple hydrolysis of the latter using a mixture 
of TFA/H 2 0 (95:5) afforded Tbfm-L-A1aOH (57) in 69% yield. 
2.6 • 3 Ligand-Exchancze ChromatoaraDhy 
This work was carried out by a colleague (Quianhong 
Wan)l 3 l. 
A solution of Tbfm-L-Ala OH in acetic acid (3 mg/mi) 
was loaded onto an analytical HPLC column packed with 
graphitised carbon (50 x 4.6 mm). The percolation of the 
material through the column was monitored by liv at 320 nm. 
When the column was fully saturated with the amino acid 
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derivative, the now coated column was then eluted with an 
aqueous copper acetate solution (C = 1 mM; monitored by UV 
at 254 mn). 
In a typical experiment 1 to 3 pg of racemates 
dissolved in water were used per injection. Detection of 
the amino acids was by UV at 254 nnt. For each 
enantiomeric mixture resolved, the absolute configuration 
was assigned by loading pure samples of each. of the 
enantioiners on the column in separate experiments. 
The results obtained are described below (Table 2). 
racemates k' 	(mm) aDL = k'L/k,D 
± Pro D 7.15 1.6 L12 
± Thr D 6. 0 2.33 L 14.6 
D 7.75 
± Ser L 13.0 1.68 
± Val D 8.25 1.61 L 13.25 
k' refers to the capacity factor (retention time). aDL is 
the ratio of the capacity factors for the D and L 
enantiomers of the analyte and gives an indication of the 
selectivity. 
Table 2 
In all the cases complete resolution was achieved with 
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a good selectivity (> 1.5). 
In view of the good results obtained, for Tbfm-L-Ala 
OH, other Tbfm amino acid derivatives were prepared and 
tested as chiral chelators. 
Both Tbfm-L-Phe OH (53) and Tbfm-L-Pro OH (62) were 
synthesised from mesylate (60) and obtained in good 
yields, following the procedure used for Tbfm-L-Ala OH 
(57) (section 2.6.2). 
Unfortunately, the results obtained by ligand-
exchange chromatography on a PGC column proved 
disappointing. 
In the case of Tbfm-L-Phe OH, the initial resolution 
of the racemate (± Pro) was successful and complete 
separation of the enantiomers was obtained. However, upon 
regenerating the column with the copper acetate solution, 
the resolution was lost. Perhaps this was because the 
coating of this compound onto the PGC column was carried 
out differently. In this case, the adsorption was 
obtained by directly immersing the packing material in the 
solution instead of pumping the solution through the 
column. 
Using Tbfm-L-Pro OH, no resolution of racemates could 
be achieved. This is possibly due to the fact that this 
compound is not stable in solution (e.g. CH 3COOH or CHC1 3 ) 
and decomposes to give the corresponding olef in and 
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proline (as judged by t.l.c.). Under the slightly acidic 
conditions of the experiment, the tertiary amine may be 
protonated allowing a possible fl-elimination to take 
place. 
To improve reliability, the method needs further 
development. 
In particular, the use of homologous derivatives with 
an additional methylene group between the Tbfm group and 
the amino acid would be advantageous. This modification 
would prevent fl-elimination and act as a spacer. 
2.7 CONCLUDING REMARXS 
The strong affinity of the Tbfm group for graphitised 
carbon (PGC) has found application for both the 
purification of peptides and the resolution of raceinates 
by 1 igand-exchange chromatography. 
Although PGC was used for both these studies, a recent 
survey of other support materials has shown that 
equivalent binding of the Tbfm group can be obtained with 
activated charcoal. This could provide a cheaper support 
material than the rather expensive PGC, and thus its use 
should be considered. 
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CHAPTER 3 : EXPERIMENTAL 
3.1 NOTES 
All amino acid derivatives were purchased from either 
Fluka, Aldrich or Sigma. Melting points were taken in 
open capillaries on an electrically heated Btjchi 510 
melting point apparatus, or on microscope slides on an 
electrically heated Reichert 7905 hot stage and are 
uncorrected. Thin-layer chromatography (t.l.c.) was 
carried out using plastic sheets coated with silica gel 60 
GF-254 (Merck 5735) in the following systems: 







methanol/chloroform/acetic acid (1:9: 0.5) 
n-butanol/acetic acid/water (3:1:1) 
Visualisation of the compounds was achieved by a 
suitable combination of the following methods: iodine 
vapour, ultraviolet absorption at 254 nm or 352 nm, 
neutral potassium permanganate and bromophenol blue 
sprays, Nary's reagent (4,4 1 -bis (dimethylamino) diphenyl 
carbinol) for acid functions and ninhydrin for compounds 
with free amino groups. Optical rotations were measured 
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on an AA 1000 polarimeter using a 1 dm cell in the 
solvents quoted in the text. High performance liquid 
chromatography (HPLC) was performed using either a Waters 
system i.e. 2 x 600 A pumps, a U6K injector, a 680 
automatic gradient controller and a model 441 ultraviolet 
detector; or an Applied Biosystems system, i.e. 2 x 1406 A 
solvent delivery system, a 1480 A injector/mixer and a 
1783 A detector/controller. Analytical separations were 
carried out on a Whatman Partisil-5 ODS-3 (4.6 mm ID x 250 
nun) and on a ABI (RP18) aquapore OD-300, 300 A pore size, 
7 pm spherical silica (4.6 mm ID x 220 nun) column under 
the conditions indicated in the text. Flash 
chromatography was performed using silica gel 60 (230-400 
mesh (Fluka); 60-100 g of silica per gram of crude 
material; active length 15-20 cm). Infrared spectra were 
recorded on a Perkin Elmer 781 spectrophotometer in the 
solvent indicated or by the KBr disc technique, using 
polystyrene as the standard (1603 cm 1 ). Ultraviolet 
spectra were recorded on a Cary 210 spectrophotometer and 
fluorescence spectra on a Perkin Elmer LS-5 luminescence 
spectrophotometer. Mass spectra were measured on a Kratos 
MS 50 TC machine. Proton nuclear magnetic resonance (NNR) 
spectra were recorded on either Brüker WP 80 (80 MHz), WP 
200 (200 MHz) or WH 360 (360 MHz) machines in the solvent 
indicated, using external tetramethylsilane as the 
standard (6 = 0.00). Carbon-13 NMR spectra were recorded 
on a Brüker WP 200 (50 MHz) or Wil 360 (90 MHz) machines in 
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the solvent indicated, using tetraxnethylsilane as the 
standard. Elemental analyses were carried out on a Carlo 
Erba model 1106 elemental analyser. Single crystal X-ray 
structure determination was performed on a Stoë Stadi-4 
four-circle diffractometer, graphite-monochromated (CUK a 
radiation; X = 1.54184 A) . All solvents were distilled 
before use and the following were dried using the reagents 
given in parentheses when required: benzene (sodium wire), 
chloroform (phosphorus pentoxide), dichloromethane 
(calcium hydride), diethyl ether (sodium wire), dioxan 
(neutral alumina and sodium wire), methanol 
(magnesium-iodine), toluene (sodium wire). Petrol (b.p. 
40-60°C) refers to that fraction which boils between 40°C 
and 60°C. 
3.2  EXPERIMENTAL 
Methyl (phenanthren-9-yl .phenvl)cilycolate (25) 129 
To a cold (0°C) solution of 9-bromophenanthrene 
(2.57 g, 10 minol) in dry ether (10 ml) under nitrogen, was 
added a solution of n-butyllithium in hexane 127 (8 ml, 
11 nunol; 1.1 equiv; 1.38M titrated 144 ) dropwise over 
10 mm. The reaction mixture was stirred for one hour at 
room temperature. The resultant suspension was allowed to 
settle and then the supernatant removed by syringe. The 
residue was resuspended in ether (5 ml). This solution 
was added, under nitrogen, to a cold (0°C) solution of 
methyl benzoylformate (1.64 g, 1.4 ml, 10 mmol) in 50 ml 
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of diethylether. The resulting mixture was heated under 
reflux for 2h and allowed to stir overnight. After 
addition of dilute (10% v/v) HC1 (50 ml; pH=l), the 
organic layer was separated, combined with ether washings 
(2 x 50 ml) of the aqueous layer, washed with water (2 x 
50 ml) and dried with NgSO 4 . The solvent was removed 
under vacuum to give a yellow oil. After purification by 
flash chromatography (eluent: (A)), a yellow oil was 
obtained which was triturated with petrol. A white solid 
was obtained which was filtered and dried in a vacuum 
desiccator to give the required compound (1.75 g, 51%); 
m.p. 143-145°C (1it. 12 138.5-139.5 0C); (Found: C, 79.7; H, 
5.24 C 23H 180 3 requires: C, 80.7; H, 5.26%); t.1.c. Rf(A) 
0.32; Rf(B) 0.76; umax  CH 2 C1 2 3690 (free OH), 3510 (H 
bonded OH), 3025 (CH stretching, aryl), 2960, 2880, 2860 
(CH stretching, alkyl), 1730 (CO, ester), 1600, 1500 
(aromatic rings), 1225, 1185, 1170, 1110, 1100, 1070 (CO 
stretching) cni'; Xmax 296 (9832), 284 (9200), 276 
(11981), 254 (48450), 248 (37620) nm; 6H  (CDC1 3 , 200 MHz) 
8.72 (1H, d, 3J = 8 Hz, aromatic), 8.66 (1H z d, 3J = 8 Hz, 
aromatic), 8.16 (1H, d, 3J = 8 Hz, aromatic), 7.75-7.25 
(11H, m, aromatic), 4.32 (lH, s, OH), 3.85 (3H, S, CH 3 ); 
6c (CDC1 3 , 50 MHz) 175.7 (CO, ester), 141.1, 135.6, 131.3, 
130.6, 130.3, 129.8 (quaternary aromatic C's), 1291, 
128.2, 128.1, 127.3, 127.0, 126.9, 126.6, 126.2, 126.1, 
122.9, 122.2 (aromatic CH's), 82.1 (C 1 , quaternary), 53.4 
(eli 3 ); m/z (El) 342, 283, 105. 
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13-Methoxycarbonyldibenzo(ac) fluorene (26)129 
Polyphosphoric acid145 (60 g) was heated to 110°C and 
stirred with a mechanical stirring paddle. To this was 
added methyl (phenanthren- 9 -yl, phenyl) glycol ate (5 g, 14.6 
ininol). The mixture was stirred for 1 hour at 110°C. The 
reaction was then cooled to room temperature, diluted with 
water (150 ml) and extracted with ethyl acetate (4 x 250 
ml). The organic layers were combined, washed with NaHCO 3 
(10% v/v; 200 ml), water (100 ml) and dried over MgSO 4 . 
The solvent was removed in vacuo to give a yellow residue. 
This crude material was purified by flash chromatography 
using toluene as the eluent. After chromatography the 
required compound (2.82 g, 60%) could be isolated. This 
solid was recrystallised from CH 2 C1 2/ petrol (b.p. 
40-60°C) to afford a white powder, (1.96 g, 42%); m.p. 
190-191°C (lit. 129 195-197°C); (Found: C, 85.2; H, 4.93 
C 23H 160 2 requires: C, 85.2; H, 4.94%); t.l.c. Rf(C) 0.50; 
RF(D) 0.56; Pmax  (CH 2 C1 2 ), 3040, 3020 (CH stretching, 
aryl), 2970 (CH stretching, alkyl), 1730 (CO, ester), 
1610, 1600, 1580 (aromatic rings)cm 1 ; 
Xmax 364 (540), 346 
(16200), 322 (18360), 268 (64800) nm; 6H  (CDC1 3 , 200 MHz), 
8.84-8.67 (3H, m, aromatic), 8.36 (1H, d, 3J = 7.8 Hz, 
aromatic), 7.98-7.90 (1H, m, aromatic), 7.80-7.35 (7H, m, 
aromatic), 5.16 (lH, s, CH), 3.63 (3H, S, CH3); 6C  (CDC131 
50 MHz), 172.0 (CO, ester), 142.7, 141.9, 137.4, 135.6, 
131.1, 130.0, 128.7, 128.4 (quaternary aromatic C's), 
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128.1, 127.0, 126.7, 126.3, 126.2, 124.3, 124.1, 123.8, 
123.3, 123.2, 122.9 (aromatic CH's), 53.4 (CH 3 ), 52.4 
(CH); m/z (El) 324, 265, 262, 132. 
13-Hydroxymethyldibenzo(a, c) fluorene (21) 
Diisobutylaluminium hydride (4.6 nil, 4.62 nimol; 1 N in 
CH 2 C1 2 ) was added at -65°C to a solution of 
13-methoxycarbonyldibenzo(a,c) fluorene (0.5 g, 1.54 mmol) 
in dichloromethane (10 nil). The reaction mixture was 
stirred for 3h and the temperature maintained between 
-50°C and -40°C. A white precipitate was obtained. The 
reaction mixture was treated with a mixture of acetic acid 
and water (1:1; 30 ml) and extracted with dichloromethane 
(3 x 60 ml). The organic layer was washed with saturated 
bicarbonate (50 ml), water (30 ml) and dried over MgSO 4 . 
The solvent was removed in vacuo to afford a crude solid. 
This crude solid was purified by flash chromatography 
using chloroform as the eluent. The title compound was 
obtained as a white solid which was washed with petrol 
(0.217 g, 48%); m.p. 167-168°C; (Found: C, 89.0; H, 5.39; 
C 22H 160 requires: C, 89.2; H, 5.41%); t.1.c. Rf(D) 0.26; 
Rf(E) 0.64; umax  (CH 2 C1 2 ) 3610 (free OH), 3490 (H bonded 
OH), 3060 (CH stretching), 2940, 2890 (CH stretching, 
alkyl), 1610, 1600, 1580 (aromatic rings) cm 1 ; Xmax 366 
(888), 338 (12728), 322 (14504), 266 (27232), 246 (31968) 
nm; oH (CDC1 3 , 200 MHz), 8.88-8.68 (3H, m, aromatic), 8.38 
(1H, d, 3J = 7.9 Hz, aromatic), 8.14-8.08 (1H, m, 
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aromatic), 7.81-7.33 (7H, m, aromatic), 4.45 (2H, m, Ha 
(CH 2 ) and Hc), 3.85 (1H, In, Hb,  CH 2 ), 1.64 (1H, s, OH), 6 
(CDC1 3 , 50 MHz), 146.7, 142.5, 139.4, 134.9, 130.9, 130.1, 
128.7 (quaternary aromatic C's), 127.5, 126.8, 126.1, 
125.9, 125.8, 124.7, 124.2, 124.1, 123.8, 123.4, 122.9 
(aromatic CH's), 65.7 (CH 2 ), 50.0 (CH); m/z (El) 296, 265. 
13-Acetoxymethyldibenzo(a,c) fluorene (30) 
13-Hydroxymethyldibenzo (a, C) fluorene (215.2 mg, 
0.727 minol) was dissolved in acetic anhydride 146 (5 ml). 
To this solution was added one drop of sulphuric acid 
(2M). The reaction mixture was stirred for 30 mm. A 
white precipitate was obtained which was filtered and 
washed with water (150 ml). The solid was finally dried 
to constant weight over P 2 0 5 in a vacuum desiccator to 
afford 13-acetoxymethyldibenzo(a,c)fluorene as a white 
solid, (206.3 mg, 84%); m.p. 135-136°C; (Found: C, 84.9; 
H, 5.33 C 24 H 18 0 2 requires: C, 85.2; H, 5.33%; t.1.c. Rf(D) 
0.57; Rf(E) 0.68; "max  (CH 2 C1 2 ) 3030 (CH stretching, aryl) 
2980, 2920 (CH stretching, alkyl) 1735 (CO, ester), 1610, 
1600, 1570 (aromatic rings) cmn 1 ; Xmax 366 (1184), 338 
(25160), 322 (27528), 265 (52688), 246 (53020) nm; 6H 
(CDC1 3 , 200 MHz), 8.86-8.69 (3H, in, aromatic), 8.38 (1H, 
33 = 7.9 Hz, aromatic), 8.30-8.25 (lH, in, aromatic), 
7.78-7.35 (7H, in, aromatic), 5.16 (1H, dxd, 33a,c = 41 
HZ, 23a,b = 10.8 HZ, Ha,  CH 2 ), 4.56 (1H, dxd, 33c,a = 4.1 
HZ, 3 c,b = 9.3 Hz, Hc), 3.76 (1H, dxd, 23b,a = 10.8 Hz, 
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3b,c = 9.3 Hz, Hb, CH 2 ), 2.17 (3H, 5, CH3); 6c (CDC1 3 , 50 
MHz) 171.0 (CO, ester), 146.7, 142.1, 138.7, 134.8 131.1, 
130.1, 128.7, 128.6 (quaternary aromatic C's), 127.6, 
127.0, 126.8, 126.2, 126.1, 125.7, 124.9, 124.8, 124.3, 
123.4, 123.3, 122.9 (aromatic CH's), 67.3 (CH 2 ), 46.5 
(CH), 20.9 (CH 3 ); m/z (El) 338, 277, 265, 139, 43. 
HPLC: column (ODS3-PL5-393, solvents: A(H 20), B(CH 3 CN), 
conditions: B(50%) 2 mm. 
B(50%) 30 min. > B (95%) 
X = 254 nm, flow rate: 1 mi/mm., injection: 5 jul, C = 
1.42 mg/mi, AUFS = 2, retention time : 21.6 mm. 
9-Fluorenylmethyl acetate (29) 
9-Fluorenylmethanol (0.215 g, 1.1 mmol) was dissolved 
in acetic anhydride146 (5 ml). To this solution was added 
2 drops of sulphuric acid (2M). This was stirred for 
30 mm. The clear solution was poured onto cold water 
(20 ml). The precipitate obtained was collected on a 
B{khner filter and dried to constant weight over P 20 5 in a 
vacuum desiccator to afford 9-f luorenylmethyl acetate as a 
white solid, (0.175g, 67%); m.p. 83-84°C (lit. 148 87°C); 
(Found: C, 80.5; H, 5.98 C 16H 140 2 requires: C, 80.7; H, 
5.88%); t.l.c. Rf (D) 0.50; Rf (E) 0.68; umax (2C12) 
3030 (CH stretching), 2960, 2910 (CH stretching, alkyl), 
1735 (CO, ester), 1610 (aromatic rings) cm 1 ; Xmax 300 
(2476), 290 (2063), 268 (7634) nm; 6H  (CDC1 31  80 MHz), 
7.83-7.29 (8H, m, aromatic), 4.46-4.28 (3H, in, CH, CH2), 
2.14 (3H, s, CH3); 6c (CDC1 31  50 MHz), 170.8 (CO, ester), 
143.6, 141.1 (quaternary aromatic C's), 127.6, 126.9, 
124.9, 119.9 (aromatic CH's), 66.2 (CH 2 ), 46.5 (CH), 20.8 
(CH 3 ); m/z (El) 238, 178, 165, 149, 60, 43. 
HPLC: column (ODS3-PL5-393), solvents: A(H 20), B(CH 3 CN) 
Conditions: B(50%) 2 mm. 
B(50%) 30 mm. ) B (95%) 
X = 254 nfl, flow rate: 1 mi/mm., 
injection: 5 tl, C = 1.46 mg/mi, AUFS = 2, retention time 
8.4 mm. 
Ethvl/ 2-oxo-2-(mDhenanthren-9 '-vi) acetate (32) 
To a stirred solution of 9-bromophenanthrene (5.14 g, 
20 mmol) in dry ether (20 ml), was added at 0°C under 
nitrogen, a solution of n-butyilithium in hexane127 
(16 ml, 22 mmol; 1.1 equiv; 1.38N titrated) 144 dropwise 
over 10 mm. The reaction was stirred for lh at room 
temperature. The resultant suspension was allowed to 
settle and the supernatant was removed by syringe. The 
residue was resuspended in ether (10 ml). This suspension 
was added, under nitrogen, to a cold (0°C) solution of 
diethyl oxalate (3.4 ml, 25 mmoi) in ether (100 ml). The 
temperature was maintained between 0°C and 5°C during the 
addition. The reaction mixture was then stirred for 2h 
between 0°C and 5°C and finally at room temperature for 2h. 
After addition of dilute HC1 (100 ml; 10% v/v), the 
organic layer was separated, combined with ethyl acetate 
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washings (3 x 100 nil) of the aqueous layer, neutralised 
with NaHCO 3 solution (100 ml; 1M), washed with water (50 
ml) and dried over MgSO 4 . The solvent was removed in 
vacuo to give an orange oil which was triturated with 
petrol (b.p. 40°C-60 0C). The title compound was obtained 
as a yellow solid which was filtered and dried, (3.53 g, 
63%); m.p. 67-68°C; (Found: C, 77.5; H, 5.02 C 18H 140 3 
requires: C, 77.7; H, 5.04%); t.l.c. Rf (A) 0.56, Rf (D) 
0.52; umax  (CH 2 C1 2 ) 3070 (CM stretching, aromatic), 2990, 
2940, 2910, 2880 (CH stretching, alkyl), 1735 (CO, ester), 
1680 (CO, ketone), 1620, 1575 (aromatic rings) cm'; Xniax 
328 (9822), 286 (7784), 252 (34842) rmi; oH (CDC1 3 , 200 
MHz) 9.04 (1H, in, aromatic), 8.62 (2H, m, aromatic), 8.23 
(1H, s, H 10 aromatic), 7.92 (1H, d, 3J = 7.6 Hz, 
aromatic), 7.78-7.59 (4H, in, aromatic), 4.51 (2H, q, 3J = 
7.1 Hz, CH 2 ), 1.48 (3M, t, 3J = 7.1 Hz, CM3), 6C  (CDC131 
50 MHz) 188.5 (CO, ketone), 164.4 (CO, ester), 137.2 
(aromatic CM), 132.8 (quaternary aromatic), 130.5, 130.2 
(aromatic CM's), 129.2, 128.1 (quaternary aromatic C's), 
128.0, 127.4, 127.1, 126.3, 122.7, 122.6 (aromatic CH's), 
62.3 (CH 2 )
1 
 14.0 (CM 3 ); ni/z (El) 278, 205, 177, 176. 
Ethyl (bis-phenanthren-9-yl)glycolate (33) 
To a stirred solution of 9-bromophenanthrene (2.57 g, 
10 nimol) in dry ether (10 nil) was added, at 0°C under 
nitrogen, a solution of n-butyllithium in hexane 127 (8 ml, 
11 nunol; 1.1 equiv.; 1.38 M titrated) 144 dropwise over 
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10 mm. The reaction mixture was stirred for lh at room 
temperature. This solution was added, under nitrogen, to 
a cold (0°C) solution of ethyl,2-oxo-2-(phenanthren-9 1 -
yl)acetate (2.78 g, 10 iamol) in ether (50 ml). The 
temperature was maintained between 0°C and 5°C during the 
addition. The reaction mixture was finally stirred at 
room temperature for 2h. After addition of dilute HC1 
(50 ml; 10% v/v) the organic layer was separated, combined 
with ethyl acetate washings (3 x 250 ml) of the aqueous 
layer, neutralised with a solution of NaHCO 3 (1M; 200 ml), 
washed with water (200 ml) and finally dried over NgSO 4 . 
The solvent was removed in vacuo to give a residue. After 
purification by flash, chromatography using chloroform/ 
petrol (b.p. 40°C-60 0C) (4:1), the expected product was 
obtained from the fractions containing material of Rf = 
0.23. After recrystallisation from dichloromethane/petrol 
(b.p. 40°C-60 0C)., a white solid was obtained which was 
filtered and dried to give the title compound (2.11 g, 
46%); m.p. 188-189°C; (Found: C, 83.1; H, 5.23 C 32H 240 3 
requires: C, 84.2; H, 5.26%); t.l.c. Rf (E) 0.71; Rf (D) 
0.48; umax  (CH 2 C1 2 ) 3680 (free OH), 3510 (H bonded OH), 
3060 (CH stretching, aromatic), 2990, 2940 (CH stretching, 
alkyl), 1735 (CO, ester), 1600 (aromatic rings) cm'; xmax 
332 (629), 300 (25080), 288 (23560), 256 (123120) nm; 6H 
(CDC1 3 , 200 MHz), 8.80-8.69 (4H, m, aromatic), 8.51 (1H, 
s, H 10 , aromatic), 8.47 (1H, 5, H 10 , aromatic), 7.72-7.41 
(12H, m, aromatic), 4.46 (lH, s, OH), 4.41 (2H, q, 3J = 
92 
7.1 Hz, CH 2 ), 1.17 (3H, t, 3j = 7. 1 Hz, CH3), oc (CDC131 
50 MHz) 175.7 (CO, ester), 135.0, 131.4, 130.6, 130.5, 
130.1 (quaternary aromatic C's), 129.2, 128.2, 127.3, 
126.6, 126.2, 126.1, 122.9, 122.3 (aromatic CH's), 84.3 
1' quaternary), 62.9 (CH 2). 13.8 (Cl! 3 ); m/z (El) 383, 
206, 177, 176. 
17-Ethoxycarbonvltetrabenzo(a,c,g. i) fluorene (34) 
Polyphosphoric acid145 (20 g) was placed in a three 
necked 100 ml round bottom flask equipped with a 
mechanical stirring paddle. Ethyl (bis-phenanthren-9-yl) 
glycolate (0.402 mg, 0.881 nunol) was then added and the 
reaction was stirred at 140°C for 4h and subsequently at 
room temperature overnight. The reaction mixture was 
diluted with water (50 ml) and extracted with ethyl 
acetate (4 x 50 ml). The organic layer was neutralised 
with NaHCO 3 (iN; 2 x 30 ml), washed with water (30 ml) and 
dried over NgSO 4 . After removal of the solvent in vacuo a 
residue was obtained which was purified by flash 
chromatography (eluent : benzene). The fractions 
containing material of Rf = 0.68 were evaporated to give 
the title compound as a yellow solid which was washed with 
petrol, filtered and dried (189 mg, 49%); m.p. 165-166°C; 
(Found: C, 84.4; H, 4.66 C 32H 220 2 requires: C, 87.7; H, 
5.02%); t.l.c. Rf (F) 0.68, Rf (D) 0.62; umax  (2d12) 
3060 (CH stretching, aromatic), 2990, 2960, 2920, 2860 (CH 
stretching, alkyl), 1810 (CO, lactone), 1735 (CO, ester), 
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1610, 1500 (aromatic rings) cm'; Xmax 386 (6371), 370 
(7964), 302 (22697), 290 (10894), 254 (42208) nm; 6H 
(CDC1 3 , 200 MRz) 8.78-8.61 (6H, m, aromatic), 8.28-8.21 
(2H, m, aromatic), 7.75-7.55 (8H, m, aromatic), 5.39 (1H, 
5, CH), 4.04 (2H, q, 3J = 7.1 Hz, CH 2 ), 0.97 (3H, t, 3J = 
7.1 Hz, CH 3 ); ôc (CDC1 3 , 67 MHz) 171.9 (CO, ester), 138.3, 
138.2, 131.6, 130.5, 128.6, 127.7 (quaternary aromatic 
C's), 127.6, 127.1, 126.2, 126.1, 125.0, 123.9, 123.4, 
123.2 (aromatic CH's), 61.4 (CH 2 ), 54.9 (CH), 13.8 (CH 3 ); 
m/z (El) 438 (N). 
17-Hydroxymethyltetrabenzo(a,c,g. i) fluorene (31) 
Diisobutylaluminiuin hydride (12.3 ml, 12.3 mmol; 3 
equiv.; iN solution in CH 2C1 2 ) was added dropwise at -65°C 
to a solution of 17-ethoxycarbonyltetrabenzo(a,c,g,i) 
fluorene (1.795 g, 4.098 mmol) in dry distilled 
dichioromethane (25 ml). The temperature was maintained 
between -65°C and -60°C during the addition. The reaction 
mixture was stirred for lh at -65°C and at room 
temperature for a further hour. The reaction mixture was 
cooled to -30°C. An aqueous solution of acetic acid (50 
ml; 10% v/v) was then added dropwise. After separation of 
the two layers, the aqueous phase was extracted with 
dichioromethane (3 x 100 ml). The combined organic phases 
were washed with water (70 ml) and neutralised with 
NaHCO 3 . Finally the organic phase was dried over MgSO 4 
and evaporated to give a crude oil (1.7 g). After 
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purification by flash chromatography using benzene as the 
eluent, the fractions containing material of Rf = 0.14 
were evaporated to give a yellow solid. This was 
recrystallised from CH 2C1 2/petrol (b.p. 40°C-60 0C) to 
afford the title compound as a yellow solid (1.18 g, 73%); 
m.p. 202-203°C; (Found: C, 91.2; H, 4.96 C 
3 0 H  2 0 0 requires: 
C, 90.9; H, 5.05%); t.l.c. Rf (F) 0.15, Rf (A) 0.18, Rf 
(B) 0.75; umax (CH 2 C1 2 ) 3600 (free OH), 3060 (CH 
stretching, aromatic), 2940, 2900 (CH stretching, alkyl), 
1610, 1500 (aromatic rings), 1045 (CO stretching) cur'; 
Xmax 380 (10692), 368 (11484), 302 (27324), 290 (21780), 
254 (43560) nm; 6H  (CDC1 3 , 200 MHz), 8.80-8.63 (6H, in, 
aromatic), 8.27-8.22 (2H, in, aromatic), 7.73-7.56 (8H, in, 
aromatic), 5.05 (1H, t, 3J = 4.3 Hz, CH), 4.49 (2H, d, 3J 
= 4.3 Hz, CH 2 ), 1.31 (lH, S, OH); 6C  (CDC1 3 , 50 MHz), 
141.6, 137.3, 131.4, 130.4, 128.5, 127.9 (quaternary 
aromatic C's), 127.4, 126.9, 126.1, 125.9, 125.0, 124.5, 
123.4 (aromatic CH's), 66.5 (CH 2 ), 50.8 (CH); m/z (El) 396 
(M), 366. 
17-Acetoxymethyltetrabenzo(a. c,g, 1) fluorene (35) 
17-Hydroxymethyltetrabenzo(a,c,g, i)fluorene (0.207 g, 
0.522 mmol) was dissolved in acetic. anhydride 146 (4 ml). 
To this solution was added 2 drops of H2SO4 (2M). The 
reaction mixture was stirred for ].h. The title compound 
was obtained as a yellow solid which was washed with water 
(80 ml) and dried to constant weight over P 20 5 in a vacuum 
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desiccator (183.8 mg, 80%); m.p. 209-210°C, (Found: C, 
87.0; H, 5.08 C 32H 220 2 requires: C, 87.7; H, 5.02%); 
t.1.c. Rf (A) 0.32, Rf (F) 0.22; umax (CH 2 C1 2 ) 3060 (CH 
stretching, aromatic), 1740 (CO, ester), 1610, 1500 
(aromatic rings), 1230, 1045 (CO, stretching) ciu'; >max 
380 (17885), 368 (19345), 302 (45260), 290 (36865), 254 
(72271) nm; oH (CDC1 31 80 MHz), 8.83-8.57 (6H, m, 
aromatic), 8.29-8.17 (2H, in, aromatic), 7.78-7.54 (8H, in, 
aromatic), 5.12 (1H, t, 3j = 5.5 Hz, CH), 4.60 (2H, d, 3J 
= 5.5 Hz, CH 2 ), 1.84 (3H, s, CH3); 6C  (CDC1 3 , 50 MHz) 
170.7 (CO, ester), 141.8, 137.0, 131.5, 130.4, 128.6, 
128.0 (quaternary aromatic C's), 127.4, 126.8, 126.1, 
126.0, 125.0, 124.9, 123.5, 123.3 (aromatic CH's), 67.9 
(CH 2 ), 47.1 (CH), 20.7 (CH 3 ); m/z (El) 438 (M), 378, 364. 
17-Methylenetetrabenzo(a,c,g, i) fluorene (38) 
A solution of 17-hydroxymethyltetrabenzo(a, c,g, i) 
fluorene (50 mg, 0.126 inmol) and triethylamine (1 ml, 
7.17 imnol; 57 equiv.) in dichioromethane (2 ml) was 
stirred overnight at room temperature. T.1.c. (eluent 
(C)) showed only the presence of the starting material. 
Phosgene (1 ml, 1.93 mole; 15 equiv; 1.93 M in toluene) 
was then added. A red colouration of the reaction mixture 
was immediately observed and a gas was released. The 
reaction mixture was stirred for 5 mm, then diluted with 
water (50 ml) and acidified with H2SO4 (2M; pH=1). After 
extraction with dichioromethane (3 x 30 ml), the combined 
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organic phases were washed with water (2 x 50 ml) to 
neutrality and dried over MgSO 4 . The solvent was removed 
in vacuo to give an orange residue. Purification by flash 
chromatography (eluent (C)) gave the title compound as a 
red crystalline solid (7.3 mg, 15%); m.p. 169-170°C; 
(Found: C, 94.9; H, 4.90 C 30H 18 requires: C, 95.2; H, 
4.76%); t.l.c. : Rf (C) 0.79, Rf (F) 0.87; Xmax 454 
(2700), 328 (44280), 314 (50220), 260 (87480) nm; oH 
(CDC1 31 80 MHz) 8.82-8.41 (8H, m, aromatic), 7.77-7.51 
(8H, m, aromatic), 6.92 (2H, s, CH2); o (CDC1 3 , 50 MHz) 
147.1, 136.8, 133.4, 131.6, 131.1, 128.5, 127.4 
(quaternary aromatic C's and quaternary C (alkene)), 
127.8, 127.3, 126.3, 125.6, 125.2, 124.7, 123.7, 123.5 
(aromatic CH's), 122.8(CH 2 ); m/z (FAB) 378 (M+). HRMS  
378.14082, C 30H 18 requires : 378.14084 (:.) < 1 ppm. 
17- (Trimethylsilyl)oxymethyltetrabenzo (a, c.g. fl fluorene 
(39) 
A solution of 17-hydroxymethyltetrabenzo(a, c,g, i) 
fluorene (0.65 g, 0.126 mmol) and N,N'-bis-trimethyl-
silyl urea147 (32.3 mg, 0.158 mmol; 2.6 equiv.) in 
dichioromethane (2 ml) was heated under reflux for 3h. 
The precipitated urea was filtered of f and washed with 
dichioromethane (2 x 1 ml). The solvent was removed in 
vacuo to give a residue. Purification by wet flash 
chromatography (benzene/petrol (b.p. 40-60°C) (75:25)) 
gave the title compound (47.8 mg, 81%); m.p. 130-131°C; 
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(Found: C, 84.2; H, 6.06 C 33 H 280 Si requires: C, 84.6; H, 
5.98%); t.1.c. Rf (F) 0.58, Rf (A) 0.51, Rf (G) 0.76; 6H 
(CDC1 31  80 MHz) 8.86-8.62 (6H, in, aromatic), 8.49-8.37 
(2H, in, aromatic), 7.79-7.51 (8H, in, aromatic), 5.11 (1H, 
t, 3J = 5.3 Hz, CH), 4.13 (2H, d, 3J = 5.3 Hz, CH 2 ), 0.4 
(9H, s, 3xCH 3 ); o (CDC1 3 , 67 MHz) 143.4, 136.5, 131.4, 
130.3, 129.0, 128.1 (quaternary aromatic C's), 127.4, 
126.5, 125.9, 125.8, 125.6, 124.9, 123.5, 123.0 (aromatic 
CH's), 67.2 (CH 2 ), 51.4 (CH), -1.0 (3XCH 3 ); m/z (El) 468 
(M), 378, 364. 
17-Tetrabenzo(a, c,g, 1) fluorenymmethyl chioroforinate (37) 
To 	a 	solution 	of 	17-(trimethylsilyl)oxymethyl 
tetrabenzo(a,c,g,i)fluorene (0.177 g, 0.38 mmol) in 
dichioromethane (5 ml) was added phosgene (1.5 nil, 
2.9 mmol; 7.5 equiv; 1.93M in toluene). The reaction 
mixture was heated under reflux for 2h and then stirred at 
room temperature for 48h, under nitrogen. The solvent was 
removed in vacuo to give the title compound as a yellow 
solid which was recrystallised from dichloroinethane/ 
n-hexane and dried (36.9 mg, 21%); m.p. 188-189°C; (Found: 
C, 80.9; H, 4.29; N, 0.45 C 31 H 19 0 2 C1 requires: C, 81.1; H, 
4.14%); Pmax  (CH 2 C1 2 ) 3060 (CH stretching, aromatic), 1775 
(CO, chloroformate), 1610, 1500 (aromatic rings), 1160, 
1140 (CO stretching) cm'; 6H  (CDC1 3 , 200 MHz) 8.79-8.60 
(6H, in, aromatic), 8.20-8.15 (2H, m, aromatic), 7.76-7.57 
(8H, in, aromatic), 5.17 (1H, t, 3J = 5.7 Hz, CH), 4.77 
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(2H, d, 3J = 5.7 Hz, CH 2 ); 6 	(CDC1 3 , 50 MHz) 150.5 (CO, 
chloroforinate), 140.3, 137.2, 131.6, 130.5, 128.2, 127.7 
(quaternary aromatic C's), 
125.1, 124.5 1  123.5, 123.4 
46.5(CH). 	- 
127.5, 127.0, 126.3, 126.2, 
(aromatic CH's), 74. 6(CH 2 ), 
17-Tetrabenzo(a , c,g, i) fluorenylmethy]. N-succinimidyl 
carbonate (40) 
To a solution of 17-tetrabenzo(a,c,g,i)fluorenyl-
methyl chloroformate (26.8 mg, 0.0585 minol) and N-hydroxy-
succinimide (6.7 mg, 0.0585 mmol) in dichloromethane (2 
ml) was added N,N'-dimethylaniline (7.4 Al, 0.0585 mmnol). 
The reaction mixture was stirred overnight under nitrogen. 
The solvent was removed in vacuo and the residue obtained 
was recrystallised from dichloromethane/petrol (b.p. 
40-60°C) to give the title compound as a yellow solid 
(11.6 mg, 37%); m.p. 212°C; (Found: C, 77.0; H, 4.25; N, 
2.16 C 35 H 23 N0 5 requires: C, 78.2; H, 4.28; N, 2.61%); umax 
(CH 2 C1 2 ) 3060 (CH stretching, aromatic), 2990 (CH 
stretching, alkyl), 1815, 1790, 1750 (imide carbonyl and 
carbonate), 1610, 1500 (aromatic rings) cm'; 368 
(39738), 302 (99882), 292 (83772), 255 (128880) rim; o 
(CDC1 3 , 80 MHz) 8.86-8.60 (6ff, in, aromatic), 8.34-8.22 
(2H, m, aromatic), 7.86-7.58 (8H, m, aromatic), 5.30 (1ff, 
t, 3J = 5.9 Hz, CH), 4.76 (2ff, d, 3J = 5.9 Hz, Ca 2 ), 2.76 
(4H, s, 2xCH 21  succinimnide); 6c  (CDC1 31 50 MHz) 168.2 (CO, 
succinimide), 151.8 (CO, carbonate), 140.7, 137.2, 131.8, 
99 
130.5, 128.4, 127.8 (quaternary aromatic C's), 127.5, 
127.4, 126.4, 126.2, 125.1, 124.9, 123.6, 123.3 (aromatic 
CH's), 74.8 (CH 2 ), 46.6 (CH) 25.3 (2xCH 21  succinimide); 
xn/z (FAB) HRMS (MH) found: 538.16544; C 35H 24N0 5 requires: 
538.16543 (.•.) < 1 ppm. 
17-Tetrabenzo(a. c,cI, i) fluorenylinethvl-p-nitrophenvl 
carbonate (41) 
To a solution of 17-hydroxymethyltetrabenzo(a,c,g,i) 
fluorene (0.05 g, 0.126 nunol) and p-nitrophenyl chloro-
formate (35.5 mg, 0.175 mmol; 1.4 equiv.) in dichioro-
methane (2 ml) was added N,N'-dimethylaniline (16 zl, 
0.126 nunol). The reaction was stirred at room 
temperature, under nitrogen, for 24h. The reaction was 
driven to completion by adding more p-nitrophenyl 
chloroformate (45 mg, 0.223 mmol; 1.7 equiv.) and by 
stirring at room temperature for a further 48h. After 
purification by flash chromatography using toluene as the 
eluent, the fractions containing material of Rf=0.29 were 
evaporated to give a yellow oil. Trituration in petrol 
(b.p. 40-60°C) gave the title compound as a yellow solid 
(56.5 mg, 80%); m.p. 139-140°C; (Found: C, 77.7; H, 3.94; 
N, 2.29 C 37H 23N0 5 requires: C, 79.1; H, 4.10; N, 2.49%); 
t.l.c. Rf (C) 0.29, Rf (A) 0.16; umax  (CH 2C1 2 ) 3060 (CH 
stretching, aromatic), 2960, 2930, 2880 (CII stretching, 
alkyl), 1770 (CO, carbonate), 1620, 1600, 1495 (aromatic 




stretching), 860 (CH bending, p-disubstituted) cm'; Xmax 
366 (20035) 301 (52092), 289 (48085), 260 (85751), 252 
(88957) nm; 6H  (CDC1 3 , 200 MHz) 8.79-8.76 (4H, m, 
aromatic), 8.61-8.57 (2H, m, aromatic), 8.33-8.16 (2H, m, 
aromatic), 7.91 (2H, d, JAB = 8.9 Hz, p-nitrophenyl), 
7.76-7.56 (8H, m, aromatic), 6.64 (2H, d, JAB = 8.9 Hz, 
p-nitrophenyl), 5.14 (1H, t, 3J = 4.7 Hz, CH), 4.96 (2H, 
d, 3J = 4.7 Hz, Cu 2 );b c (CDC1 3 , 50 MHz) 154.9 (CO, 
carbonate), 151.6 (quaternary aromatic C 1 i), 144.9 
(quaternary aromatic C 4 ), 140.3, 137.4, 131.5, 130.4, 
128.3, 127.7 (quaternary aromatic c's), 127.4, 127.0, 
126.2, 125.1, 124.7, 124.1, 123.5, 121.2 (aromatic CH's), 
125.3 (aromatic CH 2 1 ,6 i), 121.4 (aromatic C11 3 i 5 i), 71.2 
(CH 2 ), 46.8 (CH); m/z (El) 378, 139, 44; (FAB) 561 (M), 
379. HRNS 561.15759, C3?H23N05 requires: 561.15761 (:.) < 1 
ppm. 
N-l7-Tetrabenzo(a, c,g, i) fluorenylmethoxycarbonyl 
cilycine tert-butyl ester (42) 
To a solution of 17-tetrabenzo(a,c,g,i)fluorenyl-
methyl-p-nitrophenyl carbonate (39.2 mg, 0.07 inmol) and 
glycine tert-butyl ester acetate salt (14.7 mg, 
0.077 mmol; 1.1 equiv.) in dichloromethane (1.5 ml) was 
added N,N'-dimethyl' 'aniline (18 Al, 0.14 mxnol; 2 equiv). 
The reaction mixture was stirred at room temperature, 
under nitrogen, for 72h. After addition of water (10 ml) 
and acidification with KHSO 4 (2M; pH=1), the reaction 
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mixture was extracted with dichloromethane (3 x 15 ml), 
washed with water (3 x 20 ml) and dried over MgSO 4 . The 
solvent was removed in vacuo to give an orange oil which 
was triturated in ether. A yellow solid was obtained 
which was filtered, washed with petrol (b.p. 40-60°C) and 
dried to give the title compound (30.6 mg, 79%); m.p. 
170-171°C; (Found: C, 79.7; H, 5.51; N, 2.33 C 3 H 31 NO 4 
requires: C, 80.3; H, 5.60; N, 2.53%); t.1.c. Rf (H) 0.79, 
Rf (I) 0.95; umax  (CH 2 C1 2 ) 3440 (secondary amide NH), 3060 
(CH stretching, aromatic), 2940 (CH stretching, alkyl), 
1725 (CO, urethane, ester and amide I), 1600, 1500 
(aromatic rings), 1520 (amide II), 1340 (OH bonding) cm', 
1220, 1160, 1110(CO stretching), 865, 850 (out of plane CH 
bending) cm'; Xmax 384 (16323), 367 (17656), 302 (42641), 
290 (34313), 262 (62296) nm; oH (CDC1 3 , 80 MHz) 8.85-8.60 
(6H, m, aromatic), 8.39-8.28 (2H, m, aromatic), 7.81-7.56 
(8H, m, aromatic), 5.27 (1H, t, 3j = 6 Hz, CH), 4.98 (1H, 
s broad, NH), 4.61 (2H, d, 3J = 6 Hz, CH 2 ), 3.74 (2H, d, 
3J = 6 Hz, CH 2 glycine), 1.44 (9H, s, CH3x3); 6c  (CDC13, 
50 MHz) 168.7 (CO, ester), 156.1 (CO, urethane), 141.9, 
136.7, 131.5, 130.3, 128.7, 127.9 (quaternary aromatic 
C's), 127.4, 126.8, 126.0, 125.8, 125.3, 124.9, 123.5, 
123.1 (aromatic CH's), 82.0 (quaternary C, CNe 3 ), 69.0 
(CH 2 ), 47.5 (CH), 43.2 (CH 2 , glycine), 27.9 (CH 3x3); m/z 
(FAB) 553, 379. HRNS 553.22527, C 37H 31 N0 4 requires 
553.22529 (:.) < 1 ppm. 
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Na 17Tetrabenzo(a, c,g, i) fluorenylmethoxycarbonyl 
glycine, Tbfmoc GLYOH (36) 
A solution of N-17-tetrabenzo(a,c,g, i) fluorenyl-
inethoxycarbonyl glycine tert-butyl ester (0.392 g, 
0.708 xnmol) and p-toluenesulphonic acid (39.2 mg 
0.206 mmol) in dichioromethane (15 ml) was heated under 
reflux for 4.5h, during which time a precipitate was 
formed. This precipitate was filtered, washed with 
dichioromethane (2 x 15 ml) and dried to afford the title 
compound (319 mg, 90%); m.p. 240-241°C; (Found: C, 77.7; 
H, 4.5; N, 2.0 C 33 H 23 N0 4 requires: C, 79.7; H, 4.63; N, 
2.82%); t.l.c. Rf (H) 0.56, Rf (I) 0.80; Pmax  (KBr disc) 
3320 (NH stretching), 3060 (CH stretching, aromatic), 1735 
(CO, acid), 1710 (CO, urethane), 1680 (amide I), 1540 
(ainide II), 1610, 1500 (aromatic rings), 1435 (CH 
deformations, alkyl); 1310 (OH bending), 1260, 1240, 1175, 
1160, 1040 (CO stretching), 1000, 745, 720 (out-of-plane 
CH bending) ciu'; Xmax 382 (21744), 368 (23297), 303 
(55913), 291 (45041), 264 (82005), 255 (88839) nm; 6H 
(d-dioxan, 200 MHz), 9.05-8.97 (4H, 2xd, aromatic), 8.83 
(2H, d, 3J = 7.8 Hz, aromatic), 8.64 (2H, d, 3J = 7.8 Hz, 
aromatic), 7.95-7.74 (8H, m, aromatic), 6.53 (1H, t, 3j = 
5.8 Hz, NH), 5.61 (1H, t, 3J = 5.1 Hz, CH), 4.78 (2H, d, 
3J = 5.1 Hz, Cl! 2 ), 3.96 (2H, d, 3J = 5.8 Hz, CH 2 glycine); 
oc (d-dioxan, 50 MHz) 170.6 (CO, acid), 156.2 (CO, 
urethane), 142.5, 136.2, 131.3, 130.0, 128.7, 127.7 
(quaternary aromatic C's), 127.0, 126.5, 125.6, 125.4, 
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124.5, 123.3, 122.8 (aromatic CH's), 68.3 (CH 2 ), 47.6 
(CH), 41.5 (Cl! 2 , glycine); m/z (FAB) 497, 397. 	HRNS 
498.17053, C 33H 24N0 4 requires 498.17052 (..) < 1 ppm. 
HPLC: column (RP 18), solvents: A (H 20/TFA(0.1%)), 
B(CH 3 CN/TFA(0.1%)); 	conditions: 	B 	(75%), 	A 	(25%); 
X=229 mn,AUFS=2 or X=368 nm,AUFS=1; flow rate: 1 mi/mm; 
injection: 25 gil, C=1.3 mg/mi (dioxan/water (1:1)), 
retention time: 5.4 mm. 
(17-Tetrabenzo(a. c,g, i) fiuorenyl)mnethyl methane- 
sulfonate) (60) 
To 	a 	suspension of 	17-hydroxymethyltetrabenzo 
(a,c,g,i)fiuorene (0.20 g, 0.505 mmnol) and methane-
suiphonic anhydride (0.92 g, 5.32 niinoi, 10.5 equiv.) in 
dichioromethane (8 ml) was added N,N'-dimethylaniline 
(160 zi, 1.26 mmol; 2.5 equiv.). The reaction mixture was 
stirred overnight at room temperature under nitrogen. The 
solvent was removed in vacuo to give a residue. After 
purification by flash chromatography (eluent (F)), the 
fractions containing material of Rf = 0.26 (F) were 
evaporated to give an orange oil. Trituration in 
diethylether gave the title compound as a yellow solid 
which was filtered and dried (181.7 mg, 76%); m.p. 
178-181°C; (Found: C, 78.2; H, 4.59 C 31 H 220 3 S requires: C, 
78.5; H, 4.64%); t.1.c. Rf (C) 0.13, Rf (F) 0.26; umax 
(CH 2 C1 2 ) 3060 (Cl! stretching, aromatic), 2920 (CH 
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stretching, alkyl), 1610, 1500 (aromatic rings), 1360, 
1175 (SO 3 ), 1230, 1040 (CO stretching), 990, 970, 940 
(out-of-plane CH deformation) cm'; 6H  (CDC1 3 , 200 MHz) 
8.74 (4H, 2xd, aromatic), 8.58 (2H, d, 3J = 7.9 Hz, 
aromatic), 8.16 (1H, d, 3J = 6.6 Hz, aromatic), 8.15 (1H, 
d, 3j = 6.2 Hz, aromatic), 7.75-7.54 (8H, m, aromatic), 
5.01 (1H, t, 3j = 5.0 Hz, CH), 4.76 (2H, d, 3J = 5.0 Hz, 
CH 2 ), 2.19 (3H, s, CH3); a (CDC1 3 , 50 MHz) 140.1, 137.3, 
131.5, 130.4, 128.1, 127.6 (quaternary aromatic C's), 
127.4, 127.1, 126.3, 126.2, 125.1, 124.4, 123.5, 123.4 
(aromatic CH's), 72.4 (CH 2 ), 47.1 (CH), 36.6 (CH 3 ); in/z 
(FAB) 474 (M+), 379. HRNS 474.12898, C 31 H 220 3 S requires: 
474.12896 (..) < 1 ppm. 
Na_17_Tetrabenzo(a,cg. i) fluorenylmethyl-L-alariine 
tert-butyl ester (61) 
To a suspension of alanine tert-butyl ester 
hydrochloride (80.7 mg, 0.444 mmol; 2 equiv.) in ethyl 
acetate (4 ml) was added triethylamine (62 pl, 0.444 mmol; 
2 equiv.). The reaction mixture was stirred for 3h at 
room temperature. The precipitated triethylamine 
hydrochloride was filtered of,  f, washed with ethyl acetate 
(2 x 0.5 ml) and dried (53.9 mg, 88%). To the filtrate 
containing the free amino acid ester was added 
(17-tetrabenzo(a, c,g, i) fluorenyl)methyl methanesulfonate 
(105.2 mg, 0.222 minol) and N,N'-dimethylaniline (28.1 pl, 
0.222 mmol). The reaction mixture was stirred overnight 
105 
at room temperature. After addition of water (20 ml) and 
acidification with KHSO 4 (2M; pH=l), the reaction was 
extracted with dichloromethane (3 x 40 ml). The combined 
organic phases were washed with water (2 x 35 ml; pH 6-7) 
and dried over MgSO 4 . After filtration the solvent was 
removed in vacuo to give an orange oil. Following 
purification by flash chromatography using chloroform and 
then a mixture of chloroform/methanol (9:1) as the eluent, 
the fractions containing material of Rf = 0.79 (B) were 
evaporated to give a yellow oil. Diethyl ether was added 
and subsequently removed in vacuo to give the title 
compound as a yellow foam (88.5 mg, 76%); m.p. 65-73°C; 
(Found: C, 84.0; H, 6.39; N, 2.80 C 37H 33NO 2 requires: C, 
84.9; H, 6.31; N, 2.68%); t.l.c. Rf (B) 0.79, Rf(I) 0.86; 
umax (CH 2 C1 2 ) 3060 (CH stretching, aromatic), 2960, 2940, 
2870 (CH stretching, alkyl), 1725 (CO, ester), 1610, 1500 
(aromatic rings), 1370 (CH 3 symmetrical deformation), 
1220, 1150, 1045 (Co stretching), 850 (out-of-plane CH 
bending) cnr'; Xmax 383 (18014), 368 (18886), 302 (43874), 
290 (36610), 254 (74382) nm; 6H  (CDC1 3 , 200 MHz), 8.82-
8.64 (6H, m, aromatic), 8.39-8.25 (2H, m, aromatic), 
7.75-7.57 (8H, in, aromatic), 4.96 (1H, dxd, 3a,c = 4.7 
HZ, 3b,c = 4.4 Hz, CH), 3.56 (lH, dxd, 2a,b = 12.2 Hz, 
3a,c = 4.7 Hz, Ha(CH 2 )), 3.45 (1H, dxd, 2 a,b = 12.2 Hz, 
3b,c = 4.4 Hz, Hb(CH 2 )), 2.77 (1H, q, 3J = 7.0 Hz, a CH), 
1.15 (9H, s, CH 3 x3), 0.87 (3H, d, 3J = 7.0 Hz, CH3); o 
(CDC1 3 , 50 MHz) 174.3 (CO, ester), 143.7, 143.1, 136.7, 
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136.5,. 	131.2, 	130.2, 	128.6, 	128.5, 	127.9, 	127.8 
(quaternary aromatic C's), 127.3, 126.6, 125.7, 125.5, 
124.8, 123.3, 123.2 (aromatic CH's), 80.1 (quaternary C, 
C(Me) 3 )
1 
 57.4 (a CH), 52.0 (CH 2 ), 49.0 (CH), 27.5 (CH 3x3), 
18.2 (CH 3 ); m/z (FAB) 524 (MH+), 468. HRNS 524.25895, 
C 32 H 34NO 2 requires: 524.25894 (:.) < 1 ppm. 
Na_17_Tetrabenzo(a. c,g, U fluorenylmethyl-L-alanjne, 
Tbfm-L-Ala OH (57) 
A solution of Na_17_tetrabenzo(a,c,g, i)fluorenyl-
methyl-L-alanine tert-butyl ester (52.3 mg, 0.1 mmol) in 
trifluoroacetic acid (0.475 ml) and water (0.025 ml) was 
sonicated for 3.5h. The solvent was evaporated under 
reduced pressure to give a residue. Trituration in ether 
gave the trifluoroacetate salt of the title compound as a 
yellow solid, which was filtered off, washed with ether 
and dried (40.4 ing, 69%). A small aliquot was dissolved 
in a mixture of CH 3 COOH and H 20 and lyophilised to give an 
analytically pure sample of the acetate; iu.p. 139-142°C; 
(Found: C, 79.7; H, 5.25; N, 2.75 C 35 H 29N0 4 requires: C, 
79.7; H, 5.50; N, 2.66%); [a]b5 (TFA salt) + 163.4 0 (C = 1 
in CH 3 COOH); t.l.c. Rf 0.50 (I), Rf 0.20 (H); umax  (KBr) 
3400(NH), 3070 (CH stretching aromatic), 2920, 2850(CH 
stretching, alkyl), 1700 (CO, acid), 1620(C00), 1500 
(aromatic rings), 1450, 1435 (CH deformation, alkyl), 
1240, 1200, 1040 (CO stretching), 750, 730 (out-of-plane 
CH bending) cm'; Xmax (TFA salt) 382 (22917), 365 
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(27759), 300 (69720), 288 (56809), 252 (122660) nm; 6H 
(d 4 -acetic acid, 200 MHz) 8.81-8.72 (4H, m, aromatic), 
8.57 (2H, d, 3J=8.5 Hz, aromatic), 8.21-8.14 (2H, m, 
aromatic), 7.77-7.54 (8H, m, aromatic), 5.11 (1H, t 
(broad), CH), 4.53 (1H, dxd (broad), Ha(CH2)), 4.37 (1H, 
dxd (broad), Hb(CH2)), 3.69 (1H, q, 3J = 7.2 Hz, a CH), 
0.90 (3H, d, 3J = 7.2 Hz, CH3); 6c  (d 4- acetic acid, 50 
MHz) 172.5 (CO, acid), 138.2, 137.7, 137.4, 137.3, 131.52, 
131.48, 130.1, 130.0, 127.58, 127.54, 126.9, 126.8 
(quaternary aromatic C's), 127.2, 126.7, 126.2, 126.0, 
125.8, 124.3, 123.7, 122.8 (aromatic CH's), 57.8 (a CH), 
49.2 (CH 2 ), 44.0 (CH), 13.4 (CH 3 ); m/z (FAB) 468 (MH+), 
379. HRNS 468.19637, C 33 H 26 NO 2 requires: 468.19634 (...) < 
1 ppm. 
Na_17_Tetrabenzo(a. C. g. 1) fluorenylmethyl-L-phenylalanine 
tert-butyl ester (63) 
To a suspension of L-phenylalanine t-butyl ester 
hydrochloride (0.594 g, 2.30 mnmol; 2 equiv) in ethyl 
acetate (22 ml) was added triethylamine (319.8 1, 
2.30 mnmol; 2 equiv). The reaction mixture was stirred for 
2.5 h at room temperature. The precipitated triethylamine 
hydrochloride was filtered off, washed with EtOAc (2 x 
1 ml) and dried (0.314 g, 99%). To the filtrate 
containing the free amino acid ester was added (17-tetra-
benzo(a,c,g, i) fluorenyl)methyl methanesulfonate (0.546 g, 
1.152 nunol), N,N'-dimnethylaniline (146 pl, 1.152 mnmol) and 
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dichloromethane (5 ml). The reaction mixture was stirred 
overnight at room temperature under nitrogen. After 
addition of water (100 ml) and acidification to pH = 1 
with KHSO 4 (2 M), the reaction was extracted with 
dichioromnethane (3 x 200 ml). The combined organic phases 
were washed with water to pH 6-7 (2 x 200 ml) and dried 
over MgSO 4 . After filtration, the solvent was evaporated 
under reduced pressure to give an orange oil. After 
purification by flash chromatography using benzene 
followed by a mixture of benzene and methanol (97:3) as 
the eluent, the fractions containing material of RF = 0.09 
(benzene) were evaporated to give a yellow oil. Diethyl 
ether was added and subsequently removed in vacuo to give 
the title compound as a yellow foam (0.537 g, 78%); m.p. 
65-74°C; (Found: C, 85.9; H, 6.24; N, 2.38 C 43 H 3? NO 2 
requires: C, 86.1; H, 6.18; N, 2.34%); [aj 	+ 41.6° (C = 
1, CH 2 C1 2 ); t.l.c. Rf (F) 0.09, Rf (H) 0.80; "max  (KBr) 
3060, 3030 (CH stretching, aryl), 2980, 2920, 2850 (CH 
stretching, alkyl), 1720 (CO, ester), 1610, 1500 (aromatic 
rings), 1450,' 1435 (CH deformations, alkyl), 1390, 1370 
(CH 3 , symmetrical deformations), 1240, 1150, 1045 (CO 
stretching), 850, 750, 725, 700, 680 (CH, out-of-plane 
deformation) c1n 1 ; Xmnax 382 (22742), 368 (23742), 303 
(54982), 290 (46235), 254 (93469) nm; 6H  (CDC1 3 , 200 MHz) 
8.84-8.64 (6H, m, aromatic), 8.31-8.20 (2H, in, aromatic), 
7.76-7.58 (8H, in, aromatic), 6.97-6.82 (3H, in, aromatic 
(meta and para), phenylalanine), 6.64-6.59 (2H, in, 
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aromatic (ortho), phenylalanine), 4.90 (].H, apparent t, 
3c,a = 4.2 Hz, 3c,b = 4.5 HZ, Hc (CH)), 3.71 (1H, d X d, 
2a,b = 12.2 HZ, 3b,c = 4.5 HZ, Hb (CH 2 )), 3.45 (1H, d X 
d, 2a,b = 12.2 Hz, 3a,c = 4.2 Hz, Ha (CH 2 )), 2.84 (1H, 
t, 3J = 6.5 Hz, a CH), 2.41 (2H, d, 3J = 6.5 Hz, 0 CH 2 ), 
2.03 (1H, s (broad), NH), 1.05 (9H, S, CH 3 x 3); 
(CDC1 3 , 50 MHz) 173.1 (CO, ester), 143.5, 142.8, 137.1, 
136.7, 	131.3, 	130.29, 	130.26, 	128.5, 	128.0, 	127.9 
(quaternary aromatic C's), 128.7, 128.2, 127.6, 127.3, 
126.7, 125.8, 125.6, 124.8, 124.5, 123.3 (aromatic CH's), 
80.4 (quaternary C, C(CH 3 ) 3 ), 63.4 (a CH), 51.8 (Cl! 2 ), 
49.1 (CH), 39.0 (3 Cl! 2 ), 27.5 (Cl! 3 x 3); xn/z (FAB) 600 
(JiRJj+), 544, 379. 	HRNS 600.29021, C 43H 38NO 2 requires 
600.29024 (..) < 1 ppm. 
Na_17_Tetrabenzo(a, c. g, i) fluorenvlmethvl-L-phenylalanine, 
Tbfm-L-Phe OH (53) 
A solution of Na_17_tetrabenzo(a,c,g, i) fluorenyl-
methyl-L-phenylalanine tert-butyl ester (421.1 mg, 0.702 
mmol) in trifluoroacetic acid (3.6 ml) and water (0.2 ml), 
was sonicated for 3.5h at room temperature. The solvent 
was removed in vacuo to give a brown residue. Trituration 
in diethylether gave the title compound as a yellow solid 
which was chilled overnight, filtered, washed with ether, 
and finally dried (352.7 mg, 92%); m.p. 178-180°C; (Found: 
C, 85.2; H, 5.47; N, 2.57 C 39H 29NO 2 requires: C, 86.2; H, 
5.37; N, 2.59%); (a] ° -40.4° (C = 1, TFA); t.1.c. Rf (H) 
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0.36, Rf (I) 0.62; umax (KBr) 3090, 3060, 3030 (CH 
stretching, aryl), 1620 (C00), 1500 (aromatic rings), 
1240, 1190, 1040 (CO stretching), 750, 725, 700 (CH 
out-of-plane deformation) c1n 1 ; Xmax 384 (18868), 369 
(21267) , 304 (52447), 292 (41894), 264 (78991), 255 
(86346) nm; 6C (TFA, 50 MHz) 169.5 (CO, acid), 137.9, 
136.9, 136.1, 134.2, 131.8, 131.4, 130.5, 129.8, 126.3, 
126.1, 125.8 (quaternary aromatic C's) 128.7, 127.9, 
127.2, 127.0, 126.8, 124.8, 123.44, 123.34, 123.29, 122.2 
(aromatic CH's), 62.2 (cx CH), 50.9 (CH 2 ), 43.2 (CH), 34.2 
(f3CH 2 ); m/z (FAB) 544 (M&), 379. HRNS 544.22762, 
C 39H 30NO 2 requires: 544.22764 (:.) < 1 ppm. 
Na_17_Tetrabenzo(a, c.g. i) fluorenylmethyl-L-proljne 
tert-butyl ester (64) 
To a suspension of L-proline tert-butyl ester 
hydrochloride (411.5 mg, 1.981 mmol; 2 equiv) in ethyl 
acetate (20 ml) was added triethylamine (275 l; 1.981 
mmol; 2 equiv). The reaction mixture was stirred for 2.5h 
at room temperature. The precipitated triethylamine 
hydrochloride was filtered of,  f, washed with EtOAc (2 x 
0.5 ml) and dried (255.4 mg, 94%). To the filtrate 
containing the free amino acid ester was added 
(17-tetrabenzo(a, c,g, i) fluorenyl)methyl 	xnethanesulfonate 
(469.5 mg, 0.99 mmol) and dichioromethane (5 ml). 	The 
reaction mixture was stirred overnight at room temperature 
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under nitrogen. 	A clear orange solution was obtained. 
After addition of water (100 ml) and acidification with 
KHSO 4 (2M) to pH = 1, the reaction mixture was extracted 
with dichloromethane (3 x 200 ml). The combined organic 
phases were washed with water (2 x 200 ml) to pH 6-7 and 
dried over MgSO 4 . 	After filtration the solvent was 
removed in vacuo to give an orange oil. 	After 
purification by flash chromatography using benzene as the 
eluent, the fractions containing material of Rf = 0.23 
were evaporated to give a yellow oil. Diethyl ether was 
added and subsequently removed in vacuo to afford the 
title compound as a yellow foam which was finally dried in 
a vacuum desiccator (435.8 mg, 80%); m.p. 78-87°C; (Found: 
C, 84.8; H, 6.43; N, 2.43 C 39H 35NO 2 requires: C, 85.2; H, 
6.42; N, 2.55%); [a]-56.6° (C = 1, CH 2 C1 2 ); t.l.c. Rf 
(H) 0.59, Rf (F) 0.23; umax  (CH 2 C1 2 ) 3060 (CH stretching, 
aryl), 2960, 2940, 2870 (CH stretching, alkyl), 1725 (CO, 
ester), 1610, 1500 (aromatic rings), 1395, 1370 (CH 3 , 
symmetrical deformations), 1220, 1150 1 1040 (CO 
stretching) cm'; Xinax 384 (23210), 368 (23820), 302 
(43060), 254 (92838) nm; 6H  (CDC1 3 , 200 MHz) 8.84-8.65 
(7H, m, aromatic), 8.32 (lH, m, aromatic), 7.74-7.57 (8H, 
m, aromatic), 5.14 (1H, d X d, 3c,a = 4.19 HZ, 3 c,b = 
4.21 Hz, Hc (CH)), 3.77 (lH, d x d, 2a,b = 13.9 Hz, 3a,c 
= 4.2 Hz, Ha (CH 2 )), 3.06 (2H, m, Hb (CH 2 ) and a CH), 2.74 
(1H, m, Pro), 2.36 (lH, m, Pro), 1.87-1.57 (4H, m, Pro), 
1.32 (9H, s, CH 3 x 3); 6c (CDC1 3 , 90 MHz) 174.0 (CO, 
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ester); 145.9, 143.6, 136.2, 135.9, 131.3, 131.2, 130.3, 
130.1, 129.2, 128.7, 128.2, 128.1 (quaternary aromatic 
C's), 127.3, 126.7, 126.5, 126.2, 125.6, 125.5, 125.4, 
125.3, 124.8, 124.7, 123.4, 123.1, 122.7 (aromatic CH's), 
80.2 (quaternary C, C (CH 3 ) 3 ), 66.8 (a CH), 59.4 (5 Cl! 2 ), 
53.6 (CH 2 ), 49.5 (CH), 29.6 (3 CH 2 ), 27.8 (Cl! 3 x 3), 23.6 
(y CH 2 ); m/z (FAB) 550 (MH) 494, 379. HRMS 550.27461, 
C 39 H 36NO 2 requires: 550.27459 (..) < 1 ppm. 
Na_17_Tetrabenzo(a. C. g. i) fluorenylmethyl-L-Droline 
Tbfm-L-Pro OH (62) 
A solution of. Na_17tetrabenzo(a,c,g, i) fluorenyl-
methyl-L-proline tert-butyl ester (316.6 mg, 0.576 nunol) 
in trifluoroacetic acid (3 ml) and water (158Al) was 
sonicated for 3.5h at room temperature. The solvent was 
removed in vacuo to give a brown residue. Diethyl ether 
was added and the title compound was obtained as a yellow 
precipitate, which was chilled overnight, filtered and 
dried (295.3 mg, 84%); m.p. 121-124°C; (Found: C, 76.3; H, 
4.89; N, 2.39 C 3? F 3 H 28N0 4 requires: C, 73.1; H, 4.61; N, 
2.31%); [a] ° = + 28.60 (C = 1, CH 2C1 2 ); t.1.c. Rf (H) 
0.28, Rf (I) 0.36; umax (KBr) 3400 (NH), 3070 (CH 
stretching, aryl), 2960 (CH stretching, alkyl), 1720, 1690 
(CO, acid), 1500 (aromatic rings), 1450, 1435 (CH 
deformations, alkyl), 1240, 1180, 1130, 1045 (CO 
stretching), 755, 730 (out-of-plane, Cl! deformation) cm'; 
nax 384 (12564), 368 (14359), 302 (36796), 290 (29392), 
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262 (54745), 254 (61027) run; 6H  (CDC1 3 , 200 74Hz) 8.74-8.48 
(6H, in, aromatic), 8.04-7.96 (2H, in, aromatic), 7.75-7.47 
(8H, in, aromatic), 4.99 (1H, apparent s, Hc, CH), 4.50 
(1H, d X d, 2a,b = 13.5 HZ, 3a,c = 4.8 Hz, Ha (CH 2 )), 
4.10 (1H, apparent d, 2b,a = 13.5 HZ, Hb (CH 2 )), 3.49 
(1H, d x d, 3J = 5.3 Hz, 3J = 5.2 Hz, a CH, Pro), 2.28 
(1H, in, Pro), 1.83-1.07 (5H, in, Pro); 6 (CDC1 31  90 MHz) 
172.3 (CO, acid), 141.6, 139.9, 137.7, 137.4, 131.7, 
131.4, 130.5, 130.4, 128.1, 127.9, 127.7 (quaternary 
aromatic C's), 127.3, 127.25, 126.5, 126.3, 126.2, 125.3, 
125.1, 124.0, 123.8, 123.6, 123.5 (aromatic CH's), 69.7 (a 
CH), 60.7 (6 CH 2 ), 55.3 (CH 2 ), 47.1 (CH), 28.5 (0 CH 2 ), 
24.3 (y CH 2 ); m/z (FAB) 494 (MH), 379. HRNS 494.21201, 
C 35H 28NO 2 requires: 494.21199 (..) < 1 ppm. 
Na_17_Tetrabenzo(a c,g, 1) fluorenylmethoxycarbonyl-
L-phenylalanine tert-butyl ester, Tbfmoc-L-Phe OtBu (54) 
To a suspension of L-phenylalanine tert-butyl ester 
hydrochloride (126.7 ing, 0.491 inmol) in ethyl acetate 
(6 ml) was added triethylamine (68.5 pl, 0.491 mmol). The 
reaction mixture was stirred for 2.5h at room temperature. 
The precipitated triethylamine hydrochloride was filtered 
of,  f, washed with ethyl acetate (2 x 0.5 ml) and dried 
(65.3 ing, 97%). The filtrate was evaporated to give a 
residue which was redissolved in acetic acid. Following 
lyophilisation the acetate salt was obtained as a white 
solid (83.9 mg, 61%). 
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To a solution of 17-tetrabenzo(a,c,g,i)fluorenyl-
methyl-para-nitrophenyl carbonate (139.4 mg, 0.248 mmol) 
and L-phenylalanine tert-butyl ester acetate (83.9 mg, 
0.298 minol; 1.2 equiv) in dichioromethane (5 ml) was added 
N,N'-dimethylaniline (63 gil, 0.497 mmol; 2 equiv). The 
reaction mixture was stirred at room temperature under 
nitrogen for 120h. After addition of water (10 ml) and 
acidification with KHSO 4 (2M) to pH=l, the reaction 
mixture was extracted with dichioromethane (3 x 20 ml). 
The combined organic phases were washed with water (2 x 
15 ml) to pH 6-7 and dried over MgSO 4 . After filtration 
the solvent was evaporated under reduced pressure to give 
an orange oil. After purification by flash chromatography 
using toluene as the eluent, the fractions containing 
material of Rf=0.04 were evaporated to give a yellow 
solid. Recrystallisation from ether/petrol (b.p. 40-60°C) 
gave the title compound as a pale yellow solid which was 
filtered, washed with petrol and finally dried (73.9 mg, 
46%); m.p. 158-162°C (dec); t.l.c. Rf(C) 0.04, Rf(H) 0.84; 
"max (KBr) 3280 (NH stretching), 3060, 3030 (CH 
stretching, aryl), 2980, 2930 (CH stretching, alkyl), 1735 
(CO, ester), 1715 (CO, urethane), 1680 (aiuide I), 1610 
(aromatic rings), 1545 (amide II), 1500 (aromatic rings) 
1440 (CH deformations, alkyl), 1390, 1370 (CH 3 , 
symmetrical deformations), 1290, 1255, 1220, 1155, 1050 
(CO stretching), 850, 750, 720, 700 (out-of-plane CH 
deformation) cm'; m/z (FAB) 643 (M+), 379 HRNS 
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643.27225, C 44H 3 ,N0 4 requires : 643.27224 (..) < 1 ppm. 
Na_l7_Tetrabenzo (a. c, g, i) fluorenylinethoxvcarbonyl-L-
t,henylalanine, Tbfmoc-L-Phe OH (55) 
A solution of Na_17_tetrabenzo(a,c,g, i) fluorenyl-
methoxycarbonyl-L-phenylalanine tert-butyl ester (68.2 mg, 
0.106 nunol) in trifluoroacetic acid (950 1) and water (50 
gil) was sonicated for 2.5h. The solvent was removed in 
vacuo to give a purple residue. A mixture of diethyl 
ether and petrol b.p. 40-60°C (1:1) was added. The 
precipitate obtained was chilled overnight, filtered, 
washed with petrol and finally dried in a vacuum 
desiccator over P 20 5 to give the title compound (57.6 mg, 
93%); m.p. 137-140°C; [a] ° -50.8 (C=0.25, CH 2 C1 2 ); t.l.c. 
: Rf(H) 0.43, Rf(I) 0.89; umax  (KBr) 3410 (NH stretching), 
3060, 3030 (CH stretching, aryl), 2960, 2860 (CH 
stretching, alkyl), 1715 (CO, acid and urethane), 1610, 
1500 (aromatic rings), 1435, 1420 (CH deformations, 
alkyl), 1340 (OH bending), 1215, 1050 (CO. stretching), 
750, 730, 700 (out-of-plane CH deformation) cm'; Xivax 384 
(15794), 368 (16896), 302 (39670), 290 (32324), 262 
(59505), 254 (64647) nm; oH (CDC1 319  200 MHz) 8.80-8.58 
(6H, m, aromatic), 8.30-8.19 (2H, m, aromatic), 7.65-7.54 
(8H, m. aromatic), 7.19-7.07 (5H, in, aromatic (Phe)), 5.13 
(1H, apparent t, CH), 4.98 (1H, d, J=8.4 Hz, NH), 
4.79-4.64 (2H, m, Ha (CH 2 ) and aCH (Phe)), 4.30-4.24 (lH, 
in, Hb (CH 2 )), 3.08 (2H, m, 16 Cl! 2 (Phe)); 6 c (CDC1 3 , 90 
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MHz), 175.8 (CO, acid), 155.8 (CO, urethane), 142.6, 
141.0, 136.8, 136.5, 135.3, 131.5, 130.3, 130.1 
(quaternary aromatic C's), 129.0, 128.6, 127.4, 127.3, 
127.1, 126.8, 126.6, 125.9, 125.7, 125.5, 125.1, 124.9, 
124.8, 123.4, 123.1, 123.0 (aromatic CH's), 69.2 (CH 2 )
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54.4 (a CH), 47.4 (CH), 37.4 (0 CH 2 ); m/z (FAB) 587 (M), 
379. HRMS 588.21744, C 40H 30N0 4 requires : 588.21747 (:.) < 
1 ppm. 
Na_17.Tetrabenzo(a , c, g, i) fluorenylmethoxycarbonyl-L-
methionine methyl ester, Tbfinoc-L-Met OCH 3 (56) 
To a suspension of L-methionine methyl ester 
hydrochloride (0.300 g, 1.50 mmol) in ethyl acetate (6 ml) 
was added triethylamine (209.4 Al, 1.50 nunol). The 
reaction mixture was stirred for 40h at room temperature 
under nitrogen. The precipitated triethylamine 
hydrochloride was filtered of,  f, washed with ethyl acetate 
(2 x 0.5 ml) and dried (222.3 mg; overweight). Analysis 
of this salt by t.l.c. (CHC1 3/MeOH/CH 3COOH (9:1:0.5)) 
revealed after ninhydrin spray the presence of some 
L-methionine methyl ester hydrochloride. The filtrate was 
evaporated under reduced pressure and the residue obtained 
was redissolved in glacial acetic acid. After 
lyophilisation the acetate salt of L-methionine methyl 
ester was obtained as a white solid (220.4 mg, 66%). To a 
solution of 17-tetrabenzo(a, c,g, 1) fluorenylmethyl-para-
nitrophenyl carbonate (0.238 g, 0.424 minol) and 
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L-methionine methyl ester acetate (113.7 mg, 0.509 minol; 
1.2 equiv) in dichioromethane (5 ml) was added 
N,N'-dimethylaniline (107.6 pl, 0.848 mmol; 2 equiv). The 
reaction mixture was stirred at room temperature, under 
nitrogen and in the dark, for 96h. After addition of 
water (20 ml) and acidification with KHSO 4 (2M) to pH=1, 
the reaction mixture was extracted with dichioromethane (3 
x 40 ml). The combined organic phases were washed with 
H 2 0 (2 x 40 ml) to pH 6-7 and dried over MgSO 4 . After 
filtration the solvent was removed in vacuo to give an 
orange oil. Diethyfether was added and the title compound 
was obtained as a yl1ow precipitate which was chilled for 
40h, filtered, washed with ether and dried (130.9 mg, 
53%); m.p. 157-158°C; t.l.c. Rf (D) 0.20, Rf (B) 0.78; 
'max (KBr) 3290 (NH stretching), 3070 (CH stretching, 
aryl), 2950, 2920 (CH stretching, alkyl), 1750 (CO, 
ester), 1715 (CO, urethane), 1680 (amide I), 1610 
(aromatic rings), 1540 (amide II), 1500 (aromatic rings), 
1430 (CH deformations, alkyl), 1280, 1260, 1220, 1170, 
1050 (CO stretching), 750, 720 (out-of-plane CH 
deformation) cm1; 6H  (CDC1 3 , 200 MHz) 8.80-8.63 (6H, m, 
aromatic), 8.30 (2H, d, J=7.6 Hz, aromatic), 7.73-7.57 
(8H, m, aromatic), 5.22 (2H, m, CH and NH), 4.69 (lH, m, 
Ha (CH 2 )), 4.51 (2H, In, Hb (CH 2 ) and a CH (Met)), 3.73 
(3H, S, CH 3 (ester)), 2.39 (2H, t, J=8.1 Hz, y CH2 
(Met)), 2.02 (3H, S, c CH 3 (Met)), 1.86 (2H, m, 16 Cl! 2 
(Met)); m/z (FAB) 586 (MH+), 379. HRNS 586.20517, 
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C 37 H 32 N0 4 S requires : 586.20519 (..) < 1 ppm. 
3.3 SOLID PHASE SYNTHESIS 
All protected amino acid derivatives were purchased 
from Novabiochem and have L-stereochemistry. Solid phase 
peptide synthesis was carried out on an Applied Biosystems 
430A peptide synthesiser. The DMF used was supplied by 
Rathburn Chemicals Ltd. (peptide synthesis grade). The 
first residue of each sequence (i.e. the C-terminal 
residue) was coupled to the p-alkoxybenzyl alcohol resin 
outside the synthesiser. The extent of coupling was 
determined by deprotecting a small sample of the loaded 
resin and quantitatively checking the olefin produced by 
UV at 300 nm in the case of Fmoc-peptides and at 364 nm in 
the case of Tbfmoc-peptides (see Appendix II). Each 
residue was coupled twice (2 equiv.), firstly by the 
symmetrical anhydride method and secondly by the HOBt 
active ester method ('double coupling') (except Arg, Asn, 
Gln double coupled via HOBt ester and Gly coupled once via 
symmetrical anhydride (4 equiv.)). Preformed symmetrical 
anhydrides were prepared from Fmoc-amino acids (1 mmol) 
and DICI (0.5 inmol) with an activation time of 15 minutes, 
and HOBt esters from Fmoc-ainino acids (0.5 inmol), DICI 
(0.5 nunol) and HOBt (0.5 mniol) with an activation time of 
30 minutes. Coupling reactions were carried out over a 
period of 30-60 minutes. Capping of unreacted amino 
functions was performed for 6 minutes using acetic 
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anhydride and pyridine in DMF. 	Deprotection of the 
Fmoc-peptide-resin was achieved over a 12 minute period 
(5+3+3+1 minutes) using a solution of 20% piperidine in 
DMF. The resin was washed thoroughly with DMF at the end 
of each cycle. As a rough monitor of the couplings, the 
product solution from the deprotection steps was fed 
through an ultraviolet detector (313 nm) and its 
absorption recorded to give a series of peaks. Removal of 
peptides from the resin and simultaneous cleavage of side 
chain protecting groups were performed using a mixture of 
trifluoroacetic acid/water/scavenger (95:5:5) for 2-3 
hours. Chromatography of Na_protected peptides was 
carried out using graphitised carbon (PGC 220-224; 150-180 
pm, 100 m 2/g) in a glass column. HPLC was carried out on 
a Waters system using an ABI aquapore Prep 10 C-18 300 A 
pore size 20 14m spherical silica (10 mm ID x 250 mm) 
column for preparative separations and an ABI RP 18 
aquapore OD 300 7 ixn spherical silica (4.6 mm ID x 220 nun) 
column for analytical separations. A gradient was used, 
as specified in parentheses, between solvent A (0.1% TFA 
in water) and solvent B (0.1% TFA in acetonitrile). The 
flow rate was 1 ml/min for analytical HPLC and 5 mi/mm 
for preparative HPLC. Elution of the samples was 
monitored by ultraviolet absorption at 214 nm. Amino acid 
analyses were carried out on a LKB 4150 alpha amino acid 
analyser following sealed tube hydrolysis in constant-
boiling hydrochloric acid at 110°C for 18-36 hours. 
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Na_9_Fluorenyllnethoxycarbonyl glycylservimethionyl-
valylleucylserine. Finoc Gly Ser Met Val Leu Ser OH (44) 
The resin-bound peptide Fmoc Ser (OtBu) Met Val Leu 
Ser (OtBu)  (130.5 mg, 0.05 inmol) was sonicated in a 
solution of 20% piperidine in N,N-dimethylformamide (5 ml) 
for 20 mm, then filtered and finally washed well with 
N,N-dimethyl- formamide, dichioromethane and dioxan. Fmoc 
Gly OH (89.2 mg, 0.3 nimnol; 6 equiv.) was dissolved in 
dioxan (2 ml); 1,3-diisopropylcarbodiimide (47 tl, 0.3 
mmol; 6 equiv.) was then added and the reaction mixture 
was sonicated for 5 mm. This solution was then added to 
the resin-bound peptide previously swollen in dioxan (1 
ml). The reaction mixture was sonicated for 4.5h. The 
resin-bound peptide was filtered, washed with dichloro-
methane, ether, and dried (129.8 mg); product resin 
functionality in nunol/g: 0,334, resin loading/coupling 
percentage: 88; A 300 __ = 0.76 (resin-bound peptide: 2.52 
mg). To a mixture of resin-bound peptide (126.1 mg, 0.042 
mnmol) anisole (0.25 ml), ethy/methYl/suiPhide (0.25 ml) and 
water (0.25 ml) was added trifluoroacetic acid (10 ml). 
The reaction mixture was sonicated for 2h. The resin was 
filtered, washed with trifluoroacetic acid (2 x 1 ml) and 
chloroform (4 ml). The solvent was removed in vacuo to 
give a residue. The peptide was precipitated on addition 
of ether, filtered, washed.with ether and dried (42.7 mg); 
(Found: Ser 2 1.90, G1y 1 1.05, Val 1 0.99, Met 1 1.02, Leu 1 
1.01); m/z (FAB) 853, 837, 815 (MH+). HRNS 815.36488, 
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C 39 H 55 N 6 0 11 S 1 requires: .815.36492 (:.) < 1 ppm. 
HPLC: column RP 18, solvents: A (H 2 0/TFA (0.1%)), B 
(CH 3 CN/TFA (0.1%)); conditions: A (90%) 25 'Din. A (10%); 
X = 229 nm; AUFS = 0.2; flow rate: 1 mi/mm.; injection: 
25 Al (C = 0.4 mg/0.5 'Di (dioxan)); retention time: 14.2 
'Din. 
Np-l7Tetrabenzo(a, c,g, i) fluorenylmethoxycarbonyl- 
glycylseryiinethionyivalylleucylserjne, Tbfmoc Gly Ser Met 
Val Leu Ser OH (45) 
The resin-bound peptide Fmoc Ser (OtBu)  Met Val Leu 
Ser (OBUt)  (65.3 mg, 0.025 mmol) was sonicated in a 
solution of 20% piperidine in DMF (5 ml) for 20 mm. The 
resin-bound peptide was then filtered and washed well with 
DMF, dichloromethane and dioxan. Tbfmoc Gly OH (74.5 ing, 
0.15 mmol; 6 equiv.) was sonicated for 30 mm. in dioxan 
(2 ml). 1,3-Diisopropylcarbodiixnide (23.5 ul, 0.15 inmol; 
6 equiv.) was then added and the reaction mixture was 
sonicated for 5 mm. This solution was then added to the 
resin-bound peptide previously swollen in dioxan (1 ml). 
The reaction mixture was sonicated for 5h. The resin was 
filtered, washed well with dichloromethane, dioxan and 
ether, and then dried (58.3 mg); product resin 
functionality in mmol/g: 0.28; resin loading/coupling 
percentage: 80; A 364 , = 0.43 (resin-bound peptide: 0.85 
mg). To a mixture of resin-bound peptide (57.3 mg, 0.016 
mmol), anisole (0.25 ml), ethylinethylsuiphide (0.25 ml) 
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and water (0.25 ml), was added trifluoroacetic acid (5 
ml). The reaction mixture was sonicated for 2h. The 
resin was filtered and washed with trifluoroacetic acid (1 
ml) and chloroform (4 ml) and the solvent was removed in 
vacuo. Trituration of the residue in ether gave the 
desired peptide as a yellow solid which was filtered, 
washed well with ether and dried (17.2 mg, 69%); (Found: 
Ser 2 1.8, dy 1 0.08, Va1 1 1.00, Met 1 0.96, Leu 1 1.00; m/z 
(FAB) 1053, 1037, 1015 (MH+). HRNS 1015.42761, 
C 55H 63N 6 0 11 S 1 requires: 1015.42752 (:.) < 1 ppm. 
HPLC: column RP18, solvents: A (H 20/TFA (0.1%)); B 
(CH 3CN/TFA (0.1%)); conditions: A (75%) 22 mm. A (5%); X 
= 229 ma; AUFS = 1; flow rate: 1 ml/min.; injection: 25 pl 
(C = 0.2 mg/0.2 ml (dioxan)); retention time: 16.1 mm. 
Glvcvlservlmethionvlvalvlleucvlserine. H Glv Ser Met Val 
Leu Ser OH (46) 
A solution of Tbfmoc Gly Ser Met Val Leu Ser OH 
(29.2 mg, 28.8 mo1) in a mixture of dioxan and water 
(2:1; 15 ml) was loaded on a 9 mm diameter column packed 
with graphitised carbon (4 g). The column was then eluted 
with a mixture of dioxan and water (2:1; 60 ml). The 
deprotection was carried out by eluting the column with 
20% piperidine in a mixture of dioxan and water (2:1; 20 
ml). The fractions containing the peptide (monitored by 
t.1.c., Rf = 0 (MeOH/CHC1 3/CH 3COOH (1:9:0.5) (using 
ninhydrin) were combined and evaporated to give a residue. 
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The peptide was precipitated with ether, filtered and 
dried (14.5 mg, 85%); (Found: Ser 2 1.92, G1y 1 0.98, Va1 1 
1.03, Met 1 0.87, Leu 1 1.02; m/z (FAB) 609, 593 (MH). 
HRNS 593.29689, C 24H 45 0 9 N 6 S requires: 593.29685 (..) < 1 
ppm. 




Tbfmoc-ubiciuitin (53-76) OH (48) 
To the Fmoc-ubiquitin (54-76) resin-bound peptide 
(150 mg, 22.65 imo1) in DMF (1 ml) was added acetic 
anhydride (21.4 Al, 226 ixno1; 10 equiv.) and pyridine 
(18.2 Al, . 226 imol; 10 equiv.). The reaction mixture was 
sonicated for 30 mm. After filtration and washing with 
DMF and ether, the resin-bound peptide was sonicated for 
15 min in a solution of 20% piperidine in DMF (25 ml). 
The resin bound peptide was then filtered and washed well 
with DMF and ether. Tbfmoc Gly OH (45 ing, 0.09 mmol; 4 
equiv.) was sonicated for 30 mm. in dioxan (1.5 ml) until 
complete dissolution. To this solution was added 
1,3-diisopropylcarbodiimide (14 jul, 0.09 nutiol; 4 equiv.) 
and l-hydroxybenzotriazole (12.2 mg, 0.09 ininol; 4 equiv.). 
The reaction mixture was sonicated for 2 mm. This 
solution was then added to the resin-bound peptide 
previously swollen for 30 mm. in dioxan (1.5 ml). After 
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sonication for 3.5h, the resin-bound peptide was filtered, 
washed with dioxan and ether and dried overnight in a 
desiccator under vacuum (148.1 lug). 
Substitution efficiency: The Tbfmoc resin-bound peptide 
(2.1 mg) was sonicated for 30 mm. in a solution of 20% 
triethylamine in DMF (10 ml). The specific absorption at 
364 nm was recorded and the following results were derived 
from it: product resin functionality in mmol/g: 0.133; 
resin loading/coupling percentage: 88; A 364 = 0.505 
(resin-bound peptide: 2.1 mg). 
To the resin-bound Tbfmoc-peptide (146 mg) was added water 
(75 Al), thioanisole (75Al), anisole (75 Al) and 
trifluoroacetic acid (3 ml). The reaction mixture was 
sonicated for 2.5h. The resin was filtered, washed with 
TFA (2 x 0.5 ml) and chloroform (2 x 1 ml), and dried (24 
mg). The filtrate was evaporated under reduced pressure 
to give a residue. Trituration in ether gave the crude 
peptide as a yellow solid which was chilled overnight, 
filtered and dried (68.5 mg). A suspension of crude 
Tbfmoc-ubiquitin (53-76) (12 mg) in CH 3CN/H 20 (1:1; 0.1% 
TFA; 12 ml) was then sonicated for 2h until complete 
dissolution had occurred. Purification of this product 
was finally achieved by preparative HPLC using a reverse 
phase C-18 column (10 x 250 mm) with a gradient of A:B, 20 
to 80% B over 25 mm. and ultraviolet detection at 214 nm, 
to yield pure Tbfmoc ubiquitin (53-76) OH after lyophil-
isation as a white powder (4.5 mg); amino acid analysis: 
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ASX 2 2.14, Thr 2 1.94, Ser 2 1.87, G1x 2 2.38, G1y 3 2.73, 
Va1 1 1.14, lie 1 0.94, Leu 5 5.02, Tyr 1 0.94, His 1 1.01, 
Lys 1 0.94, Ar9 3 2.94; m/z (FAB) 3147.4 (MH+), 
HRNS 3149.64063, C 149H 219N 380 38 requires: 3149.64048 (..) < 
1 ppm; HPLC (A:B, A (90%) 25 min. ) A (10%); 214 nm; C = 




Na_acetyl_ubiquitin (54-76) OH (49) 
The resin-bound peptide Fmoc-ubiquitin 	(54-76) 
(100 mg, 0.0151 mmol) was sonicated for 30 mm. in a 
solution of 20% piperidine in DMF (25 ml), then filtered, 
and finally washed well with DMF and ether. To the resin 
bound peptide previously swollen for 30 mm. in DMF (1 ml) 
was added acetic anhydride (143 Al, 1.51 mmol; 100 equiv.) 
and pyridine (122 Al, 1.51 mnmol; 100 equiv.). The 
reaction mixture was sonicated for lh. The resin-bound 
peptide was filtered and washed with DMF and ether. To 
the resin-bound Na_acetyl_peptide was added water (50 Al), 
thioanisole (50 4), anisole (50 4) and trifluoroacetic 
acid (2 ml). The reaction mixture was sonicated for 2.5h. 
The resin was filtered, washed with TFA (2 x 0.5 ml) and 
chloroform (2 x 0.5 ml). The solvent was removed in 
vacuo. Trituration in ether gave the product as a white 
precipitate which was chilled overnight, filtered and 
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dried (43.6 mg). Purification of this peptide (23.4 mg) 
was by preparative HPLC using the same reverse phase C-18 
column with a gradient of A:B, 10 to 60% B over 16 mm. 
and UV detection at 214 rim, to give pure Na_acetyl_ 
ubiquitin (54-76) OH as a white solid after lyophilisation 
(9.7 mg); amino acid analysis: Asx 2 1.98, Thr 2 1.82, Ser 2 
1.69, G1x 2 2.33, Gly 2 2.36, Val 1 1.14, lie 1 0.91, Leu 5 
5.06, Tyr 1 0.85, His 1 1.01, Lys 1 0.98, Ar9 3 2.87; m/z 
(FAB) 2712.1 (MH), HRNS 2712.49903, C 118H 200N 37 0 36 
requires 2712.49891 (.•.) < 1 ppm; HPLC (A:B, A (90%) 
25 mm.) A (10%) ; 214 rim; C = 0.2 mg/0.2 ml (A), injection: 
25z1), Rt = 13.2 mm. 
Behaviour of Na_acetyl_ubiquitin (54-76) OH and Tbfmoc 
ubiguitin (53-76) OH on PGC 
A solution of Tbfmoc ubiquitin (53-76) OH (48) (5 mg) 
and N-acetyl-ubiquitin (54-76) OH (49) (5 mg) was 
sonicated for one hour in a mixture of CH 3CN/H 20/TFA 
(5 ml; 6:4:0.5) and loaded onto a 5 mm diameter glass 
column packed with graphitised carbon (1.4 g; PGC 220-224; 
150-180 in; 100 m 2/g; length after packing (140 mm)). The 
column was then eluted with a 50% aqueous solution of 
CH 3CN and monitored by HPLC. For each fraction the 
solvent was removed in vacuo, lyophilised and examined by 
analytical HPLC. 
The Na_acetyl_peptide (5.1,4g recovered) was totally 
eluted by 30 ml of the mixture (Rt=13.2 mm). Nothing was 
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elutedby the next 325 ml of the mixture. The column was 
then washed with pure dioxan (600 ml). HPLC showed that 
the Tbfmoc peptide (Rt=18.2 mm) was slowly eluted from 
the column along with some impurities. 
The deprotection was carried out using a 20% 
piperidine solution in a mixture of dioxan and water (1:1; 
10 ml) followed by elution of the column with dioxan 
(50 ml). The solvent was evaporated under reduced 
pressure to give a residue, trituration of which in ether 
gave a white solid (3.3 ing) corresponding to ubiquitin 
(53-76) OH (50) (Rt = 12.6 mm). 
Glvcylarginvlthreonyl leucylserylaspartyltyrosylasparaqyl-
isoleucvllutaminyl lvsvlglutamylserylthreonyl leucyihistidyl - 
leucvlvalylleucvlarginvlleucylarqinylglycylglycine, 
ubiquitin (53-76) OH (50) 
A solution of Tbfinoc-ubiquitin (53-76) OH (30 mg; 
crude peptide) in a mixture of CH 3CN/H 20 (1:1; 0.5% TFA; 
30 ml) was sonicated for 30 min until complete dissolution 
and loaded on a 5 mm diameter glass column packed with 
graphitised carbon (1.4g; PGC 220-224; 150-180 ni; 
100 m 2/g; length after packing: 140 nun). The column was 
first eluted with a mixture of CH 3CN/H 20 (1:1; 0.5% TFA; 
50 ml). After lyophilisation a residue (6.1 mg) was 
obtained which gave a major peak on HPLC (Rt = 13 mint., 
Na_acetyl_ubiquitin (55-76) or ubiquitin (54-76)). The 
column was then eluted with a mixture of CH 3CN/H 20 (1:1; 
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50 ml). 	A residue (0.4 mg) was obtained after 
lyophilisation which was found by HPLC to contain 
impurities. The deprotection was carried out using a 20% 
piperidine solution in a mixture of CH 3CN/H 20 (1:1; 50 
ml). The solvent was removed in vacuo to give a residue 
which was triturated in ether, filtered and dried (11 mg). 
This crude peptide (11 mg) was finally purified by 
preparative HPLC (reverse phase C-18 column (10 x 250 mm); 
gradient (A:B), 10 to 60% B over 25 mm; detection at 
214 nm) to give ubiquitin (53-76) OH as a white solid 
after lyophilisation (4.5 mg, 15%); amino acid analysis: 
Asx 2 2.04, Thr 2 1.88, Ser 2 1.67, Glx 2 2.27, G1y 3 3.37, 
Va1 1 1.01, lie 1 0.90, Leu 5 4.99, Tyr 1 0.93, His 1 1.01, 
Lys 1 0.96, Arg 3 2.95; m/z (FAB) 2727.8 (MH+), HRNS 
2727.50986, C 1 18H 201 N 38 0 36 requires: 2727.50981 (..) < 
1 ppm; HPLC (A:B, A (90%) 25 mm.) A (10%); 214 nm; C = 0.4 
mg/0.4 ml (A), injection: 25 Al), Rt = 12.6 mm. 
Na(17_Tetrabenzo(a. c,g, i) fluorenylmethoxycarbonvl 
glycyl isoieucvlrolvlproly1asparty1g1utaminylg1utamjny1_ 
arginylleucyl isoleucvlphenylalanylalanylglycyllysylglutamjnyl_ 
leucvlcrlutamylasPartylglycylarginylthreonylleucyl serylaspartyl - 
tyrosyl asparaqyl isoleucvlglutaminyl lysylgiutamyl servlthreonyl - 
leucylhistidvlleucylvalylleucylarqiny].leucylarqjnylqlycyl_ 
qlycine,Tbfmoc ubiquitin (35-76) OH (52) 
To the Fmoc ubiquitin (36-76) resin-bound peptide 
(109.3 mg, 7.88 pmol) in DNF (1 ml) was added acetic 
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anhydride (14.8 z1, 157.6 mo1; 20 equiv) and pyridine 
(12.8 Al, 157.6 uuol; 20 equiv). The reaction mixture was 
sonicated for lh. After filtration and washing with DMF 
and ether, the resin-bound peptide was sonicated for 15 
min in a solution of 20% piperidine in DNF (25 ml). The 
resin-bound peptide was then filtered and washed well with 
DMF and ether. Tbfmoc G1yOH (19.6 mg, 39.4 mo1; 5 equiv) 
was sonicated for 30 min in dioxan (1 ml). To this 
solution was added 1,3- diisopropylcarbodiimide (6.2 i1, 
39.4 ino1; 5 equiv) and 1-hydroxybenzotriazole (5.3 ing, 
39.4 mo1; 5 equiv). The reaction mixture was sonicated 
for 5 mm. This solution was then added to the resin-
bound peptide previously swollen in dioxan (1 ml) for lh. 
The reaction mixture was sonicated for 19h. The resin-
bound peptide was filtered, washed with dioxan, 
dichloroinethane and ether, and finally dried for 48h in a 
vacuum desiccator (102 mg). 
Substitution efficiency: The Tbfmoc resin-bound peptide 
(2.9 mg) was sonicated for 30 mm. in a solution of 20% 
triethylamine in DMF (10 ml). The specific absorption at 
364 run was recorded and the following results were derived 
from it: A = 0.265; product resin functionality in inol/g: 
50.51; resin loading/coupling percentage: 70. The 
coupling was then repeated under the same conditions (4 
equivalents of each Tbfinoc G1yOH, 1,3-diisopropyl-
carbodiimide and 1-hydroxybenzotriazole; reaction time: 
3.5h). The resin-bound peptide was filtered, washed with 
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dioxan, dichloromethane and ether, and finally dried 
overnight in a vacuum desiccator (99.5 mg). 
Substitution efficiency: A = 0.265 (resin-bound peptide : 
2.7 mg); product resin functionality in inol/g: 54.26; 
resin loading/coupling percentage: 75. 
To the resin-bound Tbfmoc peptide (96.8 mg) was added 
water (75Al), thioanisole (50Al) and TFA (2.1 ml). The 
reaction mixture was sonicated for 2.5h. The resin was 
filtered, washed with TFA (2 x 0.5 ml) and CHC1 3 (2 x 1 
ml), and dried (19.1 mg). The solvent was removed in 
vacuo to give a residue. Trituration in diethyl ether 
gave the crude peptide as a yellow solid which was chilled 
overnight, washed well with ether and finally dried 
(49.2 mg). HPLC (A:B; A (90%) 25 mxn. A (10%; 214 nm; C 
= 0.5 mg/0.5 ml (A/B (1:1)); injection 30 p1) Rt = 
19.2 mm. 
Glycyl isoleucvlprolvlprolylaspartylglutammnylglutamjny]._ 
arginylleucyl iso1eucylpheny1a1anyla1any1glycyllysy1gluaminy - 
leucvlcUutamvlasPartylglycylarginylthreonylleucylserylaspartyl 
tyrosyl asparaqyl isoleucylgiutaminyl lysyiqiutainyl servlthreonyl - 
leucyihistidyl leucylvalyl leucylarginyl leucylarginyiglycyl-
glycine. ubiquitjn (35-76) OH (51) 
A suspension of crude Tbfmoc-ubiquitin (35-76) OH 
(30 mg) in a mixture of CH 3CN/H 20 (1:1; 0.5% TFA, 25 ml) 
was sonicated for 20 mm (until complete dissolution) and 
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loaded on a 5 mm diameter glass column packed with 
graphitised carbon (1.5 g; PGC 220-224; 150-180 tm; 
100 m 2/g; active length: 15 cm). The column was first 
eluted with a mixture of CH 3 CN/H 20 (1:1; 0.5% TFA; 50 ml). 
After lyophilisation of the eluent a residue (2 mg) was 
obtained which gave a broad peak on HPLC (Rt = 13.8 mm 
(impurities)). The column was then eluted with a mixture 
of CH 3 CN/H 20 (1:1; 50 ml). A white solid (4.5 lug) was 
obtained after lyophilisation which was found by HPLC also 
to contain impurities (broad peak, Rt = 14.1 mm). The 
column was again eluted with 50 ml of a mixture of 
CH 3 CN/H 20 (1:1) and a residue (0.3 mg) was obtained after 
lyophilisation (Rt = 14.2 mm). The deprotection was 
carried out using a 20% piperidine solution in a mixture 
of CH 3 CN/H 20 (1:1; 50 ml) and was followed by an elution 
of the column with CH 3 CN/H 20 (1:1; 50 ml). The solvent 
was removed in vacuo to give a brown residue. Diethyl 
ether was added and the precipitate obtained was chilled 
overnight, filtered and washed well with ether, and 
finally dried (11.7 mg). The crude peptide (24.8 mg) was 
finally purified by preparative HPLC (reverse phase C-18 
column (10 x 250 nm); gradient (A:B), 20 to 60% B over 22 
mm; detection at 214 nm) to give pure ubiquitin (35-76) 
OH as a white solid after lyophilisation (4.4 mg); amino 
acid analysis: ASX 4 3.98, Thr 2 1.83, Ser 2 1.75, Glx 6 6.67, 
Pro 2 1.91, Gly 5 5.10, Ala 1 0.96, Va1 1 1.01, lie 3 2.99, 
Leu 7.00, Tyr 1 0.94, Phe 1 1.04, His 1 1.11, Lys 2 1.91, 
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Ar9 4 3.81; n/z (FAB) 4734.2 (MW1 ). 	HRMS 4734.57186, 
C 208H 344N 630 63 requires: 4734.57161 
(..) 
< 1 ppm; HPLC 
(A:B, A (90%) 25 min. A (10%); X = 214 nm; C = 0.1 xng/ 
0.1 ml (A); injection: 12 p1), Rt = 13.8 mm. 
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